Irish PharmaChem 2011

I N A S S O C I A T I O N W I T H P H A R M A C H E M I C A L I R E L A N D

Advanced Process Solutions and Equipment

CHANELLE MEDICAL CPHI STAND 2010

CONFERENCE BACK DROP

20sqm EXHIBITION STAND

SMALL BACK DROP

www.clipdisplay.ie

“With a varied and ever changing live events schedule

each year, the CLiP modular exhibition system gives us

superb value for money and return on our investment.

The project management team also take

all of the hassle away from exhibiting”

Chanelle McCoyDirector of Medical Business, Chanelle Medical

IS YOUR STAND ON SHOWOR IN STORAGE?Does your stand investment collect dust in storage, waiting for your big annual event, forcing you to buy a new stand for each smaller live event you attend?

The CLiP modular exhibition system is chosen time and again for its versatility. It gives you a stand that works harder for your business to keep your brand on show.

Reconfi gure your stand with our free stand design

service, for each live event you want to attend.

When not at an exhibition, utilise your CLiP system

around your business as reception displays, conference

back drops or demo kits for your sales force to get

maximum return on your investment.

Discuss your requirements with your local exhibition

specialist, Paul Smith, on 086 8283 620

or email him at [email protected]

THE FORMULA FOR EXHIBITION SUCCESS

EXHIBITION DESIGN GLOBAL SITE SERVICES TEAM PROJECT MANAGEMENT STAND HIRE SHELL SCHEME KITS GRAPHIC DESIGN

MINISTER’S FOREWORDRichard Bruton TD, Minister for Jobs, Enterprise and Innovation, assesses the progress made by Ireland’s Life Sciences sector, and identifies priorities if the sector is to be a key component in our economic recovery . . . . . . . . . . . . 3

SECTOR OVERVIEWMatt Moran, Director of PharmaChemical Ireland, argues that Ireland’s pharma and biopharma sectors are ready and willing to meet the chal-lenges ahead and can look to the future with confidence . . . . . . . . . . . . . . . . . 5

SUPPLY CHAINThe adoption of GS1 standards-based product and asset identification systems, coupled with EDI, greatly enhances the ability of all parties to secure the chain of custody throughout the healthcare supply chain . . . . . . . . . . . . . . . . . . . . 9

HEALTHCARE BIOTECHNOLOGYThe Irish BioIndustry Association (IBIA) is working hard to put Ireland centre stage in the fight against disease, writes Michael Gillen, Director, Irish BioIndustry Association . . . . . . . . . .10

COVER STORYUtilising the expertise of Cork-based company CPI Technology can improve your centrifuge yield by up to 100%! . . . . . . . . . . . . . . . . . . . 14

SOLVENTSEstablished in 1994, Soltec (Ireland) Ltd operates the only commercial solvent distillation facility in Ireland . . . . . . . 17

SCIENCE FOUNDATION IRELANDScience Foundation Ireland is invest-ing in research teams to generate new knowledge, leading edge technologies and competitive enterprises in the fields of science and engineering . . . . . . . . 18

LABORATORIESLancaster Laboratories’ innovative, award-winning, in-sourcing solution helps GMP laboratories to address the upcoming EU Directive . . . . . . . . . . 20

RECRUITMENT2011 looks to be brighter for recruitment in the pharmaceutical and Life Science sector, according to the results of a new study by Berkley Group . . . . . . . . . . 23

PHARMACEUTICAL PACKAGINGPascal Keogh, MD of Millmount Healthcare, explains how utilising CMOs and CPOs as part of a long-term strategy can help pharmaceutical manu-facturers to adapt to the demands of the modern pharmaceutical industry, while cutting costs . . . . . . . . . . . . . . . . . . . 25

RESEARCH & DEVELOPMENTPharmaChemical Ireland has identi-fied five key research areas, which will provide opportunities for the indus-try to make Ireland a global pharma centre of excellence . . . . . . . . . . . . 28

MATERIALS HANDLINGIrish Lift Trucks has announced a host of new developments to its range of Hyster forklifts and warehouse equipment . . . . . . . . . . . . . . . . . . . 30

CHEMICAL DISTRIBUTION IRELANDDirector Nessa Moyles explains the work of Chemical Distribution Ireland in the realm of industry best practice and responsible care . . . . . . . . . . . . . 33

LIVE EVENTSPaul Smith, Irish Sales Manager, Clip Exhibition and Display, explains how his company can take the stress out of organising live events . . . . . . . . . . . . 34

CONTAINMENT TECHNOLOGYProSys is on course to become the preferred supplier of Custom Containment Equipment to the pharmaceutical produc-tion industry worldwide . . . . . . . . . . . .37

PACKAGINGContego Packaging supplies the pharma-ceutical industry with cartons, leaflets, labels and blister pack foils from 10 sites across Europe, including their plant in Waterford . . . . . . . . . . . . . . . . . . . . . . .39

PORTABLE COLD STORAGEDawsonrentals Ireland offers high quality, flexible cold storage solutions, tailored to clients’ individual needs . . .41

published by: Tara publishing Co. lTd.1/2 Poolbeg Street, Dublin 2. Tel: 241 3095 Fax: 241 3010

Email: [email protected]

Managing director: Fergus Farrell director: Kathleen Belton

editorial: John Walshe advertising executive: Adrian Murphy

design and origination by: Rooney Media,

73 Block A Rockbrook, Sandyford, Dublin 18

printed by: W&G Baird

Irish Pharmachem 2011 gratefully acknowledges

the assistance of PharmaChemical Ireland in the

production of this publication.

Every effort has been made to ensure the

accuracy of the information contained in this

publication, but the publisher cannot accept

responsibility for errors or omissions.

LISTINGSChemical Suppliers . . . . . . . . . 42

General Suppliers . . . . . . . . . . 44

Company Listings . . . . . . . . . . 53

Useful References . . . . . . . . . . 64

1

Single-Use Systems Saint-Gobain controls every step of production for all our single-use fl uid transfer systems, from the in-house compounding of our biopharm and medical grades of silicone and C-Flex® thermoplastic resins to the manufacturing

of our TYGON®, Sani-Tech® and C-Flex® extruded tubings, EZ Top® container closures, Pure-Fit® SC sterile connectors and clamps, and Bio-Simplex™ overmolded assemblies.

New C-Flex® ULTRA Pump Tubing• Outperforms any TPE on the market

today tenfold*• Does not “gum” pump heads• Produced from C-Flex® pharmaceutical

grade thermoplastic elastomer• Class VI, complies with USP 24/NF19• Heat sealable and weldable• Good clarity – fl uid visible through

translucent tubing wall• Available NOW from the world’s leading

biopharm tubing manufacturer

from Saint-GobainNEW Pure-Fit® TCLNEW t TCL

Pure-Fit® SCPPuurre-Fit

Bio-Simplex® Manifolds

Bio S p x® Manifolds

Sani

-Tech

® EZ

Top®

Clo

sures

o

Sani

-Tech

pCl

osures

C-Flex® ULTRA Pump Tubing

C-Flex® ULTLL RA Pump TuTT bing

New!

Distributed locally by:

Micro Industries, Dublin: Ph 01-4639100 Micro Industries, Cork: Ph 021-4510570

* Tests performed by independent lab at 600 rpm/15 lbs back pressure.

Micro Ind_Irish_May.indd 1 5/9/11 5:04 PM

3

Minister’s Foreword

As M i n i s t e r f o r Jobs , Enterpr i se and Innovation, I am very pleased to pro-

vide this foreword for the Irish PharmaChem Yearbook and Directory.

The Life Sciences sector comprises of pharmaceuticals, medical devices and healthcare services. Certain aspects of the sector include specialist foods. We are fortunate, through many years of hard work and by having attractive enterprise policies and a skilled workforce, that we now boast some 45,000 high quality jobs across this sector, and some €44 billion in annual exports.

Because of this work, I am pleased to say that: • Nine of the top 10 pharma

and 15 of the top 25 medtech companies have operations in Ireland;

• Six of the world’s top 10 drugs are made in Ireland;• We are the number one location in Europe for Life

Sciences projects;• We are Europe’s largest device exporter per capita;• Investment in industry-related R&D in Ireland contin-

ues to rise.

A PArtnershiP APProAch

In order to build on this success to date, a partnership approach is crucial. The scientific research community in our higher education institutions must work closely with their colleagues in industry for the greater good of the economy and Irish society.

We have already seen good progress in this regard with the nurturing and development of industry-academic partnerships, supported by Government funding through Enterprise Ireland and Science Foundation Ireland. Additionally, we are seeking to energise greater collabora-tion between Irish research institutes and companies and partners in Europe. We want to see significant success

achieved for Irish based compa-nies in securing FP7 grant aid through enhanced collaboration.

As the world becomes more competitive and globalised, we must develop new and bet-ter ways of working. We must create innovative products and services and access global mar-kets to deliver them.

In this context, the increasing competence and success of Irish Life Science research continues to break new ground in critical areas. Our research teams in molecular cell biology, human genetics, glycobiology, immu-nology and cancer are all mak-ing strides of global relevance. We are extending our strong fundamental research base and moving it increasingly towards a highly productive interface with Ireland’s large pharmaceutical and medical device sectors. A

large number of research groups have also embraced new platforms for genomic and proteomics research. This is one of the future platforms, which will deliver for personalised medicine.

Looking at the global market, we see continued growth but also real challenges in securing market access and reimbursement for products that are not truly differenti-ated and designed around patient need. Being close to patients, and understanding the needs of purchasers, has never been more important as healthcare costs globally continue to rise. More than ever, the outcome defines the worth of the investment.

clinicAl reseArch FAcilities

Our on-going investments through the Health Research Board into clinical research facilities and an expanded grouping of clinical networks will support the development of better-tailored therapies for patients.

The passage of the Health Information Bill by the Oireachtas will address aspects of clinical trials and data

Future ProoFing the LiFe ScienceS Sector

Richard Bruton TD, Minister for Jobs, Enterprise and Innovation, assesses the progress made by Ireland’s Life Sciences sector, and identifies key

priorities if the sector is to be a key component in our economic recovery.

Biotechnology

protection, so that it becomes easier to develop new medi-cines and devices from Ireland. We are working with our regulators to ensure that Ireland provides a quality-based location from which to develop, launch and scale global products in healthcare. Through investments from my Department, made by IDA and Enterprise Ireland, we are working with industry to develop more efficient processes so that we can compete with lower cost locations.

The biotech sector is redefining possibilities, with new vaccines for cancer, targeted therapies for inflammatory disease and better-tolerated agents in arthritis and orphan diseases. We know that global companies wish to preserve their product integrity and manufacturing excellence.

Ireland’s declining cost base has greatly helped our competitive position at a time when global pharmaceutical companies are deciding on their future operations base. Ireland has come through these decisions very well to date. We can continue to be a global hub for small molecule manufacturing if we continuously innovate and manage costs, as other sectors are doing.

the Biotech sector

The biotech sector is performing well. With increasing R&D and some expansion within existing biopharma sites, Amgen’s acquisition of the Pfizer plant on Pottery Road for a large sterile fill and finish facility underlines our strong value proposition. Amgen is the world’s number one biotech company. In coming to Ireland, it joins other outstanding names such as Genzyme, Eli Lilly, Pfizer, Janssen Bio, Ipsen, Elanco and Merck.

All of these companies are innovating and manufac-turing for global markets, and exporting their products all over the world. In support of these activities, Ireland’s logistics and services innovation delivered new employ-ment projects in Alere, Eli Lilly, and Merck in the past 12 months. These are major financial and resource operations for EMEA, and bolster our value proposition.

We strongly endorse PharmaChemical Ireland and IDA’s challenge for companies to seek to develop services

around their core operations and expand into global hubs for their parent companies. The number of Irish sites that now operate as their main European hubs is testament to the success and importance of this strategy.

FAcing the chAllenge AheAd

Ireland faces daunting challenges from the present finan-cial crisis. We have outlined our path to recovery and we are working with our European partners to rebuild our economy and our global reputation. We are now firmly fixed back on what made us successful: making products that the world wants. Our industry is exporting strongly and lower costs have greatly improved our competitive-ness in global markets. We are conscious of the opportu-nities presented by enhanced collaboration between our industry sectors and state agencies. We want to see better co-operation and collaboration between ICT, medtech and pharmabio sectors, so that we can develop and supply the products and services of tomorrow.

We have strong capabilities in areas as diverse as soft-ware and nanotechnology. Apple has proven that tapping into customer mindsets, and truly developing innovative products that serve unmet needs, can bring outstanding results. That is the work we are trying to support. Our con-tinued support for the R&D budgets and the investments made through SFI and PRTLI confirm our commitment to the belief that we must think and export our way out of the present national difficulty.

We remain committed to maintaining our corporation tax rate at 12.5%. We are determined that the business and regulatory environments will continue to be strongly pro-enterprise. We will continue to seek to strengthen our competitiveness, through addressing issues on costs, infrastructure, access to finance, and science, technology and innovation.

We are determined to secure a bright future for indus-trial production in Ireland, to the benefit of all sectors, including, of course, pharmaceuticals and Life Sciences in general.

Richard Bruton TD,Minister for Jobs, Enterprise and Innovation

4

Minister’s Foreword

5

Sector overview

Last year, March 16 to be precise, PharmaChemical Ireland (PCI) launched a major strategy document

at the Drug Chemical and Allied Technologies (DCAT) meeting in New York City. The strategy, titled ‘Innovation and Excellence’, saw PharmaChemical Ireland set out a clear roadmap for the industry in Ireland, a roadmap designed to help the industry confront and overcome the many hurdles now placed before the sector, globally as well as locally. Since the launch, PCI has been working on execution of this strat-egy via its Standing Committee on Strategy, established around the time of the launch. PCI has received excellent support from Government, its respective agencies and the research community through their active participation in the work of this committee.

Follow-Up

PCI identified the attributes which it believed the factory of the future should possess if it were to thrive and prosper in this new, much more challenging environment. To recap, these are summarised below:

• Highly-efficient, cost-effective manufacturing with the full implementation of the principles of lean manufac-turing and operational excellence;

• Best practice in regulatory management, including principles of quality by design and process analytical technology;

• On-site process and product development capabilities fully integrated into manufacturing;

• Site of choice for transfer of all new entities to market;• Flexible and adaptable production facility;• On-site pilot plant facilities;• An on-site unit aimed at training the workforce in the

latest principles of Lean, Six Sigma, etc;• Fully networked and research infrastructure;• Best practice in systems and information management;• Best in class in all aspects of environment and health

and safety (EHS) management;

• A fully-integrated development network for overall corporate structure;

• Capacity and capability for clinical trials manufacture;• Regional HQ status for supply chain components, where it makes economic sense to concentrate them at one location;• A strong local management team;• A flexible workforce that can facilitate change on an ongoing basis.

The industry has been working to ensure that each of these attributes

is developed on all sites in this country. To date, progress has been good and as follow-up to the strategy launch in 2010, PCI will launch a follow-up report during BIO 2011 in Washington DC. This report demonstrates the progress a number of companies have made here. PCI intend to pro-mote the report extensively in the USA, as well as in Europe. Given the difficult economic times Ireland finds itself in, it is important that the country effectively promotes those parts

PCI PoInts the Way to Pharma suCCess

Matt Moran, Director of PharmaChemical Ireland, argues that Ireland’s pharma and biopharma sectors are ready and willing to meet the

challenges ahead and can look to the future with confidence.

Matt Moran, Director, PharmaChemical Ireland.

Sector overview

6

of the economy that are still prospering. With exports of over €50 billion in 2010 and employing over 24,000 directly, creating another 24,000 indirect jobs, the pharmachem sec-tor is a prime example of this.

coSt BaSe

Coupled with the above, Ireland is set to benefit from fall-ing costs. The European Commission forecasts that Irish unit labour costs will fall by over 8% in the period 2008-2012. Relative to the EU average, this is an improvement of 14%. Irish energy costs have come down substantially. During 2008, the cost of electricity for large energy users was 37% more in Ireland than in the EU-27. By 2009, this gap had narrowed to 10% and by the first half of 2010 (lat-est data available), Irish electricity prices were 8% below the EU-27 average. The price of natural gas has moved from 15% above the EU-27 average in 2007 to 7% below by the first half of 2010 (see charts below).

caSe StUdieS

The report contains a number of interesting case studies that clearly show how the industry is progressing here. The PCI strategy highlighted the importance of broadening the mandate of existing manufacturing facilities into process and product development. The Solid State Pharmacetical Cluster, established in 2008, is an excellent example of how the industry can work with the research community, with the support of Science Foundation Ireland (SFI), to achieve this.

Solid State pharmaceUtical clUSter (SSpc)

The Solid State Pharmaceutical Cluster (SSPC) offers complementary research activities to industry in areas such as chemical engineering, organic chemistry, physical prop-erty science, polymorphism, analytics and pharmaceutics.

The SSPC is intended to provide the necessary skill set to comprehensively investigate pharmaceutical solids by bringing together complementary academic and industrial groupings from the disciplines of chemistry, pharmaceu-tics, pharmaceutical technology, chemical and mechanical engineering. These groups have expertise in process mod-elling and design, scale-up, computational fluid dynamics, on-site solution and solid-phase monitoring, crystallogra-phy and powder characterisation.

The SSPC conducts industry-informed research, address-ing three key areas for industrial partners:

1. Providing industry-informed PhD’s to the sector in general;

2. Developing short term, company-specific mini projects;3. Engaging multiple company/academia researchers in

collaborative industry-wide research topics:- continuous crystallisation: determining the best

future practice in this area;- particle engineering: addressing throughput issues

around isolation and drying of API’s;- primary secondary interface: identifying the

attributes of the API/excipient that influence the formulation process.

The SSPC is supported by companies such as Clarochem, Hovione, MSD, GSK, Eli Lilly, BMS, Janssen and Pfizer, who work closely with University of Limerick (centre base), TCD, UCC and NUIG.

It has proved a very successful model and the indus-try is actively exploring ways of further developing and expanding its scope and work.

companieS deepening rootS in ireland

A number of companies are making significant progress towards becoming recognised centres of excellence in the supply, development and manufacturing of products. Just three samples of what has been achieved follow.

FormUlation r&d and manUFactUring Facility, mSd, Ballydine

In September 2007, construction started on a new formula-tion R&D manufacturing facility located on MSD’s exist-ing Ballydine site. This €100m investment, backed by the IDA, will support MSD’s commercialisation initiative to bring new medicines to market more quickly and flexibly, and will significantly increase the overall level of R&D conducted at the site.

Unit labour costforecast % change 2008-2011

-10.0 -5.0 0.0 5.0 10.0 15.0Source: European Commisson

United KingdomItaly

EU-27France

PortugalIreland

4020

0-20

Energy price differential (%)relative to EU-27 average

Electricity Gas

2007 2008 2009 2010

This worldwide centre for formulation R&D will develop innovative platforms for the formulation of solid dosage pharmaceutical products used in late stage clinical trials. The facility will also enable the plant to produce tablets/capsules for a number of new products in late stage clinical trials and manufacture launch quantities of newly approved products.

Since 2007 a total of 50 new high-calibre roles have already been introduced as part of this development, which will become fully operational in 2011.

The facility recently received its manufacturer’s license and its IMP (Investigational Medicinal Products) license from the Irish Medicines Board and is currently executing formulation development in support of two new candidate products in phase III clinical trials.

the gloBal proceSS development centre (pdc), pFizer ringaSkiddy api plant, cork

The Global Process Development Centre (PDC) was founded in 2001 to focus on developing innovative sci-ence and technology solutions to achieve operational and technical excellence in API synthesis. The PDC employs a wide range of skills across chemistry (synthesis/analytical), engineering and biocatalysis, which facilitate the develop-ment of new technology for Pfizer’s priority products to meet pre-defined environmental, cost and productivity targets. The PDC supports each step of the API process engineering project, from proof of concept through regula-tory submission to commercial implementation.

In addition, Pfizer recognised the need to have a flexible, state-of-the art modular kilo facility capable of supporting API process development. Hence, the Kilo Technology Laboratory (KTL) facility was launched in late 2008 to support the development of continuous process-

ing technology, in addition to providing pilot scale batch processing capability. This additional capability has been a key factor in allowing the PDC to continue to deliver significant cost, productivity and environmental benefits to Pfizer through the application of innovative science and technology.

eli lilly, kinSale, co cork

In addition to recent investment in state-of-the art biop-harmaceutical facilities in the last three years, Eli Lilly’s Kinsale site has been transformed into a key commer-cialisation partner for the Lilly Product Research and Development group. The site is now the first choice loca-tion for pre-validation scale-up activities for the emerging portfolio. This has been enabled by the provision of a suite of manufacturing facilities at 5, 50, 250 (in construction) and 2,000 gallon capacity, as well as parallel technology and capability in areas such as PAT, crystallisation, contin-uous processing, data-rich experimentation and advanced analytical diagnostics.

Substantial collaboration with third-level institutions has been a significant factor in the progress of this ini-tiative. Five projects have been completed to date, with several more currently in progress.

conclUSion

There can be no doubt that the next few years will be very challenging for the pharmachem and biopharma sectors in Ireland. However, PCI does believe that the sector here is more than capable of meeting these challenges. There will be change in the sector, some of it painful, but the major-ity of it transformational. The examples above give a taste of what is happening in the sector here. Taken along with the recent announcement by Amgen to purchase the Pfizer Dun Laoghaire site, I believe all bodes well for the long-term future of the sector. PCI, along with the industry, is ready and willing to play its role in leading this country to prosperous times again.

Sector overview

7

GS1 Standards enable supply

chain visibility for traceability and

authentication solutions through

unique identification of

· items

· parties

· assets

· and locations

The Nutley Building, Merrion Road, Dublin 4, Ireland.

T +353 (0)1 208 0660 F +353 (0)1 208 0670

E [email protected] W www.gs1ie.org

For information on how GS1 identification

standards can benefit your business please

contact us at:

10

HealtHcare BiotecHnology

Healthcare b io t echno l -ogy refers to a medicinal or diagnostic product or a vaccine that consists of, or

has been produced by the use of, living organisms. It has a tremendous impact on meeting the needs of patients and their families - it not only encompasses medicines and diagnostics that are manu-factured using a biotechnological process, but also gene and cell therapies and tissue engineered products.

Today, the majority of innovative medicines, whether manufactured using biotechnology or via a chemical synthesis like a traditional small molecule medicine, and many diagnostic products, are made available by applying modern biotechnol-ogy in their development and/or manufac-turing processes.

The Irish BioIndustry Association (IBIA), the representative voice of the biotechnol-ogy sector in Ireland, working closely with colleagues in EuropaBio, are committed to developing new products that help society live better, longer and healthier. By working closely with the various stakeholders, the IBIA is com-mitted to the development and implementation of sound policies that will lead to innovative solutions to unmet medical needs.

tHe impact of tHe financial crisis

Over the last two years, the financial crisis has had a dra-matic and negative impact on the healthcare biotechnology industry, not only by limiting access to finance for smaller companies, but also by pressing national governments into implementing measures to contain costs in their healthcare systems and on their science and research budgets. Often the first affected area by these cost containment measures is the spending on research into, and uptake of, innovative biotech medicines. Often short-term by nature, these meas-ures, including narrow Health Technology Assessments (HTAs) and pricing and reimbursement processes, should ensure that patients benefit in the long-term from these healthcare innovations, while ensuring health systems get value for money.

Did you know? • More than 350m patients have already

benefited from approved medicines manufactured through biotechnology to treat or prevent cancers, heart attacks, stroke, multiple sclerosis, leukemia, diabetes, rare and other diseases.

• 650 new biotech medicines and vac-cines are currently being developed for more than 100 diseases.

• In Europe, there are more than 60 approved orphan medicinal products, most of them biotech medicines, for the prevention or treatment of rare, life-threatening or serious conditions.

• Whilst the individual number of patients suffering from rare diseases might be low, all together, more than 30m Europeans are affected.

• With the completion of the human genome map-ping and the resulting improved understanding of inter-individual variability, current medical science is evolving towards a “personalised” approach, in which we are better able to develop and subsequently target medicines to patients who are more likely to benefit.

The healThcare of The fuTure

The Irish BioIndustry Association (IBIA) is working hard to put Ireland centre stage in the fight against disease, writes Michael

Gillen, Director, Irish BioIndustry Association and Senior Executive, Pharmachemical Ireland.

Michael Gillen, Director, Irish BioIndustry Association and Senior Executive, PharmaChemical Ireland.


1 1

• The pharmaceutical industry is increasingly shifting towards biotechnology. Projections estimate that in 2014, 50% of the top 100 drugs will be biotech medi-cines.

• By 2015, the OECD estimates that healthcare biotech-nological knowledge will be used in the development process for all new pharmaceuticals.

• More than 70% of biotech and pharmaceutical com-panies in the EU-27 have less than 50 employees. Although small, biotech SMEs provide the high value-added jobs that will help the EU achieve its goal of becoming the foremost knowledge-based economy in the world.

• Recently, larger biopharmaceutical companies have tended to place greater reliance on outsourced R&D, mostly coming from emerging biotech SMEs. These programmes now represent as much as 30% to 50% of the pipeline for many major companies.

• The total export value of the Irish pharma and biop-harma industry in 2010 was in excess of €50 billion. That is over half of the GDP of the country.

innovative medicine

The European Commission (EC) has launched its strat-egy to achieve a more competitive and socially inclusive European Union by 2020, as well as the first European Innovation Partnership in the field of active and healthy ageing. Furthermore, Commission Vice-President Antonio Tajani is leading a new initiative to improve access to innovative medicine in the European Union (EU) – the so-called ‘Process on Corporate Responsibility in the Field of Pharmaceuticals’. Nevertheless, there is growing concern among the healthcare biotech industry that an irreversible disconnect is emerging between the long-term access poli-cies promoted at EU level and the short-term actions taken at EU Member States level.

Healthcare biotechnology provides patients with new and targeted solutions for a wide range of major diseases, such as cancer, diabetes or stroke. However, while health-care biotechnology can support governments in their efforts to enhance the sustainability of their healthcare systems, cost containment measures can also have the contradictory effect of hampering innovation and access for patients by delaying or limiting entry into market of new technologies.

The biotechnology industry in Ireland is committed to the socially responsible use of biotechnology to improve the quality of lives, to treat and cure diseases. Indeed at a wider European level, this commitment extends to improve the quality and quantity of food, to produce chemicals and to sanitise and to prevent release of hazardous wastes. The biotechnology industry recognises its responsibility to address societal ethical concerns and to encourage,

through constructive dialogue between stakeholders, a bet-ter mutual understanding of such concerns. Underpinning this responsibility are three principles that the IBIA believe is necessary to grow the industry base in Ireland and the wider European community.

1. Achieving Better Policy Making Through ScienceScience is a fast driver of innovation, providing patients with cutting-edge healthcare solutions to address unmet medical needs. The IBIA’s role is to foster open discussion and exchange between all relevant stakeholders in order to improve the understanding of the latest developments in science. Ultimately, we believe that a better understanding of science leads to the setting of better policies.

Take for example, the issue of personalised medicine. With the completion of human genome mapping, it became clear that biology is much more complex than expected. Research into understanding inter-individual variability at several molecular levels has continued worldwide.

Private and public scientific developments are strongly driving the medical paradigm towards an approach that ensures the right treatment to the right patient at the right time. This personalised medicine approach com-bines predictive diagnostic and therapeutic tools to create predictable outcomes and tailor medical treatment to the individual characteristics of each patient. This change is not only driven by scientific advances but also by society’s demand for novel solutions to old problems and more efficient therapies.

Modern healthcare biotechnology methods and tools such as gene and cell therapies have the potential to answer this demand, providing personalised, innovative, safe and effective healthcare biotech products for patients. There are now a growing number of biomarkers, genetic and proteomic tests being developed and validated to identify patients who will most likely respond to associated treat-ments.

Applications of personalised medicine go beyond thera-peutic usage and are also increasingly used in drug devel-opment, from pre-clinical to clinical development. A variety of tools help identify respondents, non-respondents and

patients who are likely to suffer from adverse reactions. As a result, pre-clinical and clinical trials are likely to become smaller, safer, more focused, faster and less expensive.

From a public health perspective, tailoring treat-ments to patients who are most likely to derive benefits from them will contribute to a re-distribution of financial resources in healthcare systems in a more rational way. The personalised medicine approach has the potential to bring more effective and safer treatments to the market, as well as reducing the use of ineffective treatments and the number of adverse reactions – thereby reducing unneces-sary hospitalisations.

2. Achieving Regulations that Support InnovationA sound regulatory framework encourages and stimulates responsible innovation to help people live longer and healthier lives. The IBIA brings its expertise and expe-rience into all key regulatory discussions to help in the development of a predictable and workable framework. Our involvement in, and commitment to, such an approach will ultimately improve the timely access to new medicines. Furthermore, it will improve the competitiveness and attractiveness to investors of the healthcare biotech sector in Ireland.

At a European level this involves working closely with our colleagues in EuropaBio to ensure that we maintain an innovative and viable European bioscience industry that can compete globally.

3. Achieving better access to market throughout the EU Regardless of their country of residence, all patients deserve timely access to innovative therapies. However, as EU Member States increasingly resort to cost-rationing measures to contain their healthcare expenses, promoting the value and uniqueness of biotech medicines has become essential to ensure that tools such as HTA or tenders are used appropriately and do not reduce patients’ access to life-saving therapies.

The healthcare biotechnology industry is a critical source of innovation and, as such, is a key player within the EC reflection ‘Vision for European Union in 2020’. Today, the sector is seven times larger than it was 10 years ago and has a 20% annual growth rate. However, due to the com-plexity of the sector (i.e. products, policies and regulatory environment), healthcare biotech’s contribution to society is at best underestimated.

The value of an innovation tends to be split into at least two categories: breakthrough innovation and incremental innovation. Breakthrough innovation can either be estab-lished by a landmark discontinuity or be the result of dis-crete incremental improvements. Such minor increments may ultimately be just as important to patients.

An example from within the healthcare biotech area could be an improved mode of administration of a medi-cine rather than a new medicine, as such. Failing to also acknowledge and reward all categories of innovation, including incremental innovation, will undermine a vital part of the innovation process.

Our role in the IBIA is two-fold:i) To promote the medical, economic and societal benefits

of biotech innovation;ii) To engage with all relevant stakeholders in construc-

tive interactions to explore ways to maintain and to strengthen the industry’s innovative efforts.

We will continue to work to adopt a holistic approach to policy-making and implementation at a national and European level and in turn ensure effective and innovative European healthcare systems for patients’ benefit.


12

This article is adapted from the EuropaBio healthcare manifesto 2011.

Tel: +44 (0) 116 288 1588Fax: +44 (0) 116 281 3000


Web: www.measomfreer.co.uk

Measom Freer (Sales) Ltd.

37-41 Chartwell Drive, Wigston, Leicestershire LE18 2FL England.

f r o m c a p s t ob o t t l e s . . . Whether it needs dispensing, dropping or plugging, Measom Freer has an

extensive stock range of plastic dropper caps, nozzles, spouts and plugs

to complement our bottle and packaging ranges. You could find that we

have the perfect solution for dispensing your solution right here, ready

for dispensing. Whatever you need, we’ve been providing a personal

service with great attention to detail for 70 years – so you can rely on

Measom Freer to provide the ideal plastic packaging solution.

For an illustrated catalogue, or to request samples, contact our

sales department.

70Pack

aging Quality

Pack aging Q ualit yYears

• Caps & Plugs

• Dropper Caps & Dispensers

• Nozzles, Spouts & Plugs

• Bottles, Jars & Boxes

• Measures & Spatulas

• Scoops & Spoons

• Tubes & Fasteners

• Stock Products

• Bespoke Packaging

• Screen Printing

www.measomfreer.co.uk

CB

1

14

Cover Story

Based in Cork, CPI Technology are a leading provider of advanced proc-

ess equipment and specialty services to the pharmaceutical, chemical, biotechnology, food and beverage and energy gen-eration sectors in the Irish, UK and European markets.

I n c o l l a b o r a t i o n w i t h their world class partners, CPI Technology offers unrivalled expertise and experience in the provision of new capital proc-ess equipment, coupled with the optimisation and on-site servicing of existing process equipment and plant, including reactor technology and agitation, vacuum pumps and systems, pumps and fluid handling equipment, chemical dosing systems, glass lined technology, high con-tainment isolators, tank protection equipment and the subject of this article – solids liquids separation/dryer technology.

Liquid/Solids separation is recognised by many in the industry as being the most important part of the pharma-ceutical and fine chemical process, and centrifuge technol-ogy has long been considered as one of the best means of separating liquids and solids, whether the process calls for inverting, vertical or horizontal centrifuge technologies.

However, many centrifuges operate below their design capacity due to incorrect operation, inefficient process parameters, or wear and tear on the machine over time.

Together with their partner, Contecma C.S Gmbh, CPI Technology can deliver significant yield and efficiency increases from your centrifuge by closely analysing and implementing the centrifuge mechanics, process param-eters, automation and machine fine tuning.

ProCeSS oPtimiSation

There are many types of centrifuges in operation in the pharmaceutical and chemical industries in the API indus-

try today. It is true to say that centrifuge technology separates solids from liquids with a higher efficiency than all other solid liquid separation technologies, such as filter presses, filter suc-tion strainers (nutsche filter dryers), belt filters or thermal drying. Indeed, mechanical separation is approximately 10 times less expensive than thermal drying of a similar type product.

Centrifuge technologies deliver the highest yield and the driest product with the most efficient wash effect and within the shortest possible time. But this assumes the equipment is operat-ing at its peak level.

Process optimisation of a cen-trifuge begins with identifying the optimum process conditions specific to individual products for a given

machine type, together with the testing and implementation of those conditions, to deliver absolute results direct to the bottom line profit.

How to imPlement a tHree-SteP Centrifuge Plan to an imProved Bottom line:

Step 1:Mechanical checks of the centrifuge include: Mechanical inspection (O-rings, seals, bearings etc); Filter cloth selec-tion specific to product – critical and frequently incorrectload cell calibration.

Step 2:Collation and analysis of process conditions and definition of new parameters – this is typically based on historical information and is not optimised for the latest production products and demands. Some aspects in the optimisation process include reviewing:• Program settings • Wash ratios

Improve Your CentrIfuge YIeld wIth

Utilising the expertise of Cork-based company CPI Technology can improve your centrifuge yield by up to 100%!

Deliver absolute results direct to the bottom line profit with centrifuge optimisation.

• Capacity • Product data• New program creation with identified parameter

modifications

Step 3:Test runs, process fine tuning and meas-urable results in euro.• Confirmation of new program

parameters• Higher yield• Dryer product • Reduced cycle times • Improved wash process

tHe SeParation ProCeSS

Production Centrifuges typically operate between 1000 and 2000 times G-force, with the result that filtration is 1000 to 2000 times faster than filtration with a funnel. The average particle size of separation in a filter centrifuge is between 5.0mm and 0.1µm. The use a filter cen-trifuge for particles less than 0.1µm is impractical due to the limitation of effective filter cloths.

During the centrifugation / separation of a product there are several stages.

CHarging

The first stage is to charge the centri-fuge with the slurry and this is the most important step. During this stage, the filter cake is created. The slurry flows continuously into the centrifuge, form-ing the cake, while the mother liquid is drained off - process optimisation demands determination of the ideal cake thickness for an effective filtration rate of mother liquid. Solids distribution and concentration are critical for efficient cake building (see Figure 1 – Typical Particle Distribution Curve).

Figure 1: Typical Particle Distribution Curve Products with more than one peak in the particle distri-bution curves are more difficult to feed into a centrifuge, due to the possibility of separation between the larger and smaller particles.

Figure 2An integral part of the optimisation process requires

determination of the optimum fill speed and flow rate in order to build up a homogenous filter cake. This can include multiple fill steps at varying fill speeds. Understanding the particle size and the particle form (crystal-line, amorphous, needles etc) is important for the efficient operation of any centrifuge and is necessary for accurate calculation of the process parameters required to deliver

improved yields. Solids concen-tration, particle distribution, fill

speeds, flow rate and cake thick-ness all affect the next steps of the

washing and centrifugation of the product.

waSHing

In order to optimise the wash step, it is important to under-stand the reason for washing in the first place. There are generally two different reasons.

One is to remove the impurities from the mother liquid - or to displace the mother liquid from the filter cake. The second reason may be to wash a secondary product out, such as a salt or a pH from the filter cake.

During the wash optimisation step, it is important to understand whether the wash is more time dependant or wash volume dependant. Detailed analysis of the wash program can lead to reduced wash times, reduced wash volume or both. (e.g. products capable of being washed with steam instead of water can see wash volumes reduced by a factor of 100 or more).

Cover Story

15

Cover Story

0 10 20 30 40 50 60 70 80 90 100 110 120 130 140100

90

80

70

60

50

40

30

20

10

0

[%]

[µm]

Centrifugation

The Centrifugation stage normally occurs after the charg-ing of the slurry and before the washing. Once the washing stage is complete, the final centrifugation step starts and this is where analysis of the centrifugation process provides optimisation of the cycle time and centrifuge speeds.

With PAC (Pressure Added Centrifugation) examina-tion, regular spinning time can be reduced by up to 50%, depending on the product. A secondary benefit of the PAC spinning time is the reduction of the moisture content: with optimised conditions of the PAC spinning cycle a moisture content of less than 1% can be achieved.

Summary

Centrifuge optimisation requires all process parameters to be considered. Temperature affects viscosity, speed affects cake building, cake thickness affects filtration rate, filter cloth determines particle retention – and so on.

Process optimisation is a complex procedure and requires in-depth process expertise in order to obtain the highest yield from the product you produce, together with obtaining the best quality and the driest product from your centrifuge. CPI Technology, in partnership with Contecma C.S Gmbh, are at your service to gain these results and increase profits for your company. With experience of more than 500 different chemical and pharmaceutical products and applications, Contecma C.S Gmbh has many years experience of centrifuge maintenance, refurbishing and optimisation.

“CPI Technology’s successful long term partnerships with leading global clients is evidence of our on-going commitment to service,” summarises Colin Corbett, API Technical Specialist and Support, CPI Technology Ltd. “We emphasise personal involvement, responsiveness and reli-

ability in our daily interactions with our customers and we consistently strive to deliver leading edge technologies that meet and exceed our customers expectations at all times.”

Cover Story

16

For more information, please contact:

Colin Corbett,API Technical Specialist and Support,CPI Technology Ltd,Unit 5,Link Road Business Park,Ballincollig,Co. Cork.

Tel +353 (0)21 4874142Fax +353 (0)21 4878764E-mail: [email protected]: www.cpitechnology.com

filter dryerS

agitatorS and mixerS

magnetiC drive PumPS

vaCuum SyStemS

tank ProteCtion

doSing PumPS and SkidS

HigH Containment

milling & miCroniSation

glaSS lined reaCtorS

Centrifuge oPtimiSation

Sanitary equiPment

SamPling SyStemS

lined PiPe and fittingS

PeriStaltiC PumPS

BurSting diSCS

Heat exCHangerS

diaPHragm PumPS

flame arreSterS

PreSSure relief valveS

Sanitary PumPS

ESTABLISHED in 1994, Soltec (Ireland) Ltd operates the only commercial solvent distillation facil-ity in Ireland. Soltec has developed

a strong customer base throughout the country, co-ordinated from its facility in Mullingar, Co. Westmeath

Soltec are licensed through the EPA to accept up to 5,000 tonnes of waste organic solvents and recover them to a reusable product, through dry distillation technology. The recovered product is sold as ‘paint thinners’ and other industrial clean-ing agents throughout Ireland and England.

Soltec complies with the Waste Management Act 1996 and EPA Act 1992, which provide legislation goverening the tracebility and management of waste from ‘cradle to grave’. Soltec also are governed by their EPA Waste Licence (W0115-01) and ISO 9001 quality standard, while Soltec’s facility is managed under the ISO:14001 Environmental Standard.

Soltec has invested in distillation and laboratory equip-ment, which provides the necessary elements to recover solvents to a specific standard. In 2011, Soltec invested in upgrading their scrubber system to further reduce air emissions. Soltec are also in the process of installing a

computer-controlled automated drum filling system for their product packaging department.

Soltec’s strong team of technical employees is second to none, giving customers the assurance of quality throughout the production process. Environmental concerns are high on the agenda, with the company’s most recent appointment seeing a graduate of DIT’s Environmental Management Degree course taking on the role of On-site Environmental Manager.

In addition Soltec has also built up a valu-able network of waste management contractors and hazardous waste experts, which the com-

pany draws on in order to provide a high standard of service to customers.

Specifically Soltec provide solutions in the following waste streams:

Solid Waste: contaminated personal protective equip-ment, lab smalls, spray bottles, wipes, oily rags, crushed paint cans, glues, adhesives, wipes;

Liquid Waste: inks, solvents, paints, primers, lacquers; “Our aim is to help companies reduce their waste man-

agement costs and transform waste into a valuable resource while complying with relevant waste legislation,” sums up Soltec’s David Corcoran.

17

SolventS

Soltec: Ireland’S only commercIal Solvent dIStIllerS

making waste work

Hazardous WasteManagment Solutions

On Site Distillation •Recovery

Recovery of Hazardous •Solid and Liquid Waste

Suppliers of Recycling •Equipment

EPA Licensed Waste •Managment Facility

Zone AMullingar Business Park

MullingarCo. Westmeath

Tel: 044 9335133Fax: 044 9345248

[email protected]

making waste work

18

Science Foundation ireland

SINCE its establishment just over a decade ago, Science Foundation Ireland (SFI) has strategically invested over €85m in the phar-

maceutical sector, from formulation through to drug delivery. A further €424m has been allocated by SFI over the same period in the biotech/biologics sector that underpins the pharma sector.

Sustained strategic investment in these fields has been a major contributing factor in establishing Ireland as an internationally attractive location for multinationals. Today, nine of the top 10 global pharmaceutical companies have a presence in Ireland, with 11 of the world’s top 12 medical technology companies having a manufacturing base here. Ireland’s PharmaChemical industry gener-ates over half of all Ireland’s exports, and we are now the largest net exporter of medicines in the world.

This strong commercial track record has been mirrored by impressive academic rankings, with Ireland now in the top 20 countries in overall scientific global rankings, and especially strong in other fields such as immunology (where we are now ranked third).

Ireland continues to broaden its pharmaceutical hori-zons, with many new opportunities for developing novel products and processes currently being explored. Working closely with IDA Ireland, Enterprise Ireland, the Health Research Board and others, SFI is actively engaged in a collaborative agenda to enhance and expand existing works streams and commercial outputs.

Pharma-related inveStmentS

Some of the most significant SFI pharma-related invest-ments include:

• The Alimentary Pharmabiotic Centre. This SFI CSET, based at UCC, is the flagship investment that has been made by SFI in gastroenterology. Their overall remit is to investigate the means by which intestinal bacteria influence health and disease and to this end, they work towards developing new therapies for lifelong debili-tating gastrointestinal diseases such as gastroenteritis,

ulcerative colitis, and Crohns Disease. The APC has already seen the licensing of a probiotic treatment for Irritable Bowel Syndrome in the US through Procter and Gamble and has collaborations with multiple industry partners, including GSK.

• The Solid State Pharmaceutical Cluster (SSPC) led by Kieran Hodnett at UL and with co-investigators located in UCC, NUIG, UCD and TCD, carries out asso-ciated research by finding methods to rationally design solid-state pharmaceuti-cal materials in their required physical and chemical forms, through designing novel crystal synthesis and characterisation tech-niques and using theory and modelling to more clearly understand how best to pro-duce tablets and other drug formulations (www.ul.ie/sspc). The SSPC has multiple successful industry partnerships with many of the world’s leading pharmaceuti-cal companies, including Pfizer, Merck, GSK and Roche.

• The Irish Drug Delivery Network (IDDN) Strategic Research Cluster (SRC) is led by David Brayden at UCD, with four co-PIs based in UCC, TCD and the RCSI (http://www.ucd.ie/iddn). The main thrust of the IDDN’s research is to investigate novel ways of replacing injected medicines with drugs based on pro-teins and genes, which are administered either orally or through inhalation. The IDDN has forged a suc-cessful partnership with the indigenous enteric drug delivery company Sigmoid Pharmaceuticals and has other industry partners, including Genzyme.

• The Alimentary Glycosciences Research Cluster (AGRC), a strategic research Cluster (SRC) led by Professor Lokesh Joshi, SFI Stokes Professor, is based at NUIG and is a consortium of researchers from NUIG, UCD, Teagasc, NIBRT and UCC, in addition to a number of industry partners tasked to explore the role of gut glycosylation in host-microbe interactions including Agilent Technologies (HTP

ReseaRch foR IReland’s futuReScience Foundation Ireland (SFI) is committed to building a

world-class research environment in Ireland, investing in research teams to generate new knowledge, leading edge technologies and competitive enterprises in the fields of science and engineering.

19

Analytical Tech.), Alimentary Health (Probiotics and Pharmabiotics), Biomining, Inc (Biostatistical Analysis), Bristol Myers-Squibb (BioPharmaceuticals).

• The Molecular Therapeutics for Cancer Ireland Strategic Research Cluster is led by Professor John Crown. This cluster involves a consortium of sci-entists, including a number of clinical investigators, whose vision is to assemble and build a fully integrated national translational cancer drug discovery and devel-opment program for the benefit of cancer patients. Their goal is to identify biomarkers and targets, identify new indications for molecular targeted agents, under-stand the molecular basis for sensitivity/insensitivity to molecularly-targeted agents (MTAs), and find ways to monitor therapy. The therapeutic areas encompass breast, melanoma, lung and prostate cancer. Industry partners include Roche, Anti-Cancer Inc, Novartis, Amgen, Caliper Life Sciences, Merck Sharp & Dohme, GlaxoSmithKline, Erigal, and Pfizer.

the Future For reSearch

Looking to the future, having received a strong endorse-ment in Budget 2011, SFI will continue to support and collaborate with our pharmaceutical-focused research-

ers and industry partners. In terms of policy, the new Programme for Government commits to targeting scientific research and development, and has identified areas such as bioscience as among those sectors with greatest scope for innovation. Furthermore, the Government has also pledged to refocus our overall R&D and innovation policy, as part of the European Commission’s ‘Innovative Union’ propos-als, with a greater emphasis on turning inventions into products. Our scientific infrastructure and extensive net-work of personnel across enterprise and academia would suggest that Ireland has never been so well-equipped to play a leading role on the pharma stage.

For more information about SFI-supported research and details of upcoming calls, go to www.sfi.ie.

Science Foundation ireland

SFI Strategic Research Clusters (SRCs) – Life Sciences• Reproductive Biology Research Cluster, Dr

Alexander Evans UCD.• The Irish Drug Delivery Research Network

(IDDN), Prof. David Brayden, UCD.• Network of Excellence for Functional Biomaterials

(NFB), Prof. Abhay Pandit, NUIG.• Solid State Pharmaceuticals Cluster, Prof. Kieran

Hodnett, UL.• Immunology Research Centre (IRC), Prof.

Kingston Mills, TCD.• Advanced Biomimetics for Solar Energy

Conversion, Prof. James MacElroy, UCD.• Alimentary Glycoscience Research Cluster

(AGRC), Prof. Lokesh Joshi, NUIG.• Irish Separation Science Cluster, Prof. Brett Paull,

DCU. • Molecular Therapeutics for Cancer Ireland

(MTCI), Prof. John Crown (DCU).

SFI Centres for Science Engineering & Technology (CSETs) – Life SciencesAlimentary Pharmabiotic Centre (APC) at University College Cork - www.ucc.ie/research/apcThe goals of the APC include investigating the means by which intestinal bacteria influence health and disease; developing new therapies for debilitating gastrointestinal diseases (such as gastroenteritis, C. difficile, ulcerative colitis and Crohn’s Disease); exploring commercial opportunities in both the pharma and functional food sec-tor; and positioning Ireland at the forefront of this excit-ing new area. Collaborating partners: Alimentary Health, GlaxoSmithKline and Teagasc (the Irish agriculture and food development authority).

Biomedical Diagnostics Institute (BDI), Dublin City University - www.bdi.ieBDI is carrying out cutting-edge research to develop the next generation of biomedical devices that will directly affect the quality of people’s lives worldwide over the coming decades. The diagnostic devices and sensors will aim to detect minute concentrations of disease related molecules in biological samples like blood, saliva and breath. Collaborating Partners: Åmic AB (recently acquired by J&J Ortho-Clinical Diagnostics), Analog Devices Inc., Becton Dickinson and Co., Biosurfit S.A, Enfer Technologies Ltd., Hospira Inc., Inverness Medical Innovations Inc., Millipore.

Systems Biology Ireland, University College Dublin (http://www.ucd.ie/sbi/)Systems Biology Ireland will build the foundations of the science through the development of platforms and expertise in systems biology by focusing on defined sci-entific projects. In an effort to solve critical biological and biomedical problems, SBI research projects will be driven by the need to address biological questions for tangible benefits. In order to achieve a systems level understanding, the conceptual framework to rationalise complex biologi-cal relationships will come from mathematical modelling. Collaborating Partners: NUI Galway and industry part-ners Hewlett Packard, Servier, Agilent Technologies, Siemens Ireland, Ark Therapeutics and Protagen AG.

20

Laboratories

In today’s global econ-omy, most companies are being forced to cut costs and control

spending. For pharmaceuti-cal and biopharmaceutical companies in particular, common practice is mov-ing away from permanent worker contracts to avoid the associated long-term fixed costs. However, the alternative solution to replace these positions with temporary workers also now comes at a higher cost to companies in light of the new EU Temporary Agency’s Workers Directive 2008/104.

Caught in the middle of these industry changes and employment legislation, businesses are struggling to find a balance between adhering to budget constraints and securing the resources needed to meet project demands.

Cost-effeCtive in-sourCing soLution

The current dynamics of the pharmaceutical industry have created a need for a more flexible, value-added, cost-effec-tive in-sourcing solution. Lancaster Laboratories combines GMP operational experience with proven HR practices

to offer a unique service model, called Professional Scientific StaffingSM (PSS), to help alleviate headcount, co-employment, and man-agement challenges.

Lancaster Labs recruits, hires, trains and manages highly-qualified scientists to perform laboratory serv-ices at the client’s facility, using the client’s systems and equipment. These sci-entists are Lancaster Labs’ employees, managed by us,

with the same benefits, including healthcare and pension, as any other employee. They are physically located at the client’s site, using the client’s systems, equipment, and standard operating procedures. But they are supervised by our on-site manager, who oversees the team, project, and budget.

Lancaster Labs’ PSS approach solves the chal-lenges surrounding the EU Temporary Agency Workers Directive, which comes into effect on December 5, 2011. Many clients view this as an ideal solution for a flexible workforce achieved at a lower cost than fixed headcount, with no concerns about co-employment management. Utilising the PSS program is more cost-effective than hir-ing full-time employees, and avoids the turnover rate and lack of productivity that is typically seen with temporary staffing programs. In addition, all of our PSS teams meas-ure quality and productivity to drive continuous improve-ment and demonstrate value to our clients.

adaptabLe pss ModeL

Whether a client is looking for a PSS team to complete a distinct type of testing, or they are seeking a specific skill set to perform the work, we can adapt our PSS model to meet the project needs. We can also work in tandem with the client’s teams or work independently from them to meet a wide array of testing needs.

For example, Eli Lilly uses Lancaster Labs’ PSS pro-gram to perform environmental monitoring and water testing, using a team of 10 analysts and one group leader to carry out the required testing, managing their own work-

Making in-Sourcing Work For You

Lancaster Laboratories’ innovative, award-winning, in-sourcing solution helps GMP laboratories to address the upcoming EU Directive,

writes Beth DiPaolo, Managing Director, Professional Scientific Staffing, Lancaster Laboratories.

0YearsCelebrating

loads and working independently from other Lilly staff members. On the other hand, another client uses PSS in a manner that blends their employees with our PSS team members to collaborate on projects. In this case, a team of five analysts, one lead analyst and one research investiga-tor are spread throughout the site and work side-by-side in the same labs and offices as the client’s employees. The client’s managers oversee the company’s workflow and direct the Lancaster Labs’ PSS team members to where they are needed.

Infusing our 50-year track record of scientific labora-tory expertise and HR best practices with 10 years of proven success with the PSS service model, our staffing partnerships have grown to more than 350 employees, serving customers at 20 different sites in three countries, including Ireland, the US and UK, with project teams ranging in size from two to 89 team members. In addition, Lancaster Labs has been recognised with four strategic partner awards for exceeding our clients’ expectations with this program.

Balancing Budget constraints

By joining forces with Lancaster Labs, pharmaceutical and biopharmaceutical companies can receive a flexible, value-

added, in-sourcing solution delivered by a highly reputable laboratory. By choosing an in-sourcing solution, companies can reap the benefits of meeting workload demands, while minimising headcount and other challenges associated with workforce management.

If your organisation, like many others, is seeking a solu-tion to help balance budget constraints while also meeting output and testing demands, consider PSS as your in-sourcing solution to help you accomplish your project goals in the most cost-effective, productive manner. For more information about Lancaster Laboratories’ PSS program or other services, visit: www.lancasterlabspharm.com.

22

laBoratories

About the Author: W I T H L a n c a s t e r Laboratories’ Human Resources Department since 1987, Beth DiPaolo, M A , S P H R , i s t h e Managing Director of Professional Scientific Staffing.

536 Grants Crescent,Greenogue Business Park,Rathcoole,Co. DublinTel : + 353 1 4019800Sales Office : + 353 1 4019817E mail : [email protected]

Univar is Ireland’s leading source of high quality ingredients to the pharmaceutical sector. Our pur-pose built site has been designed to meet the regu-latory compliance demands of our pharmaceutical customers.

We are serious about safety and we are commit-ted to making a positive impact on environmental issues in handling fine chemicals.

Univar is the partner of choice for many of the world’s leading pharmaceutical ingredient manu-facturers.

Whether you are looking for API’S, EXCIPIENTS, PROCESS CHEMICALS, SOLVENTS, OR INTERMEDIATES we can provide technical and regu-latory support.

To discuss your specific needs please contact our sales office at +353 1 4019817

W HEN discuss ing the marketplace over the last few months, Berkley has encountered a mixed

interpretation on the state of our economy at present. Based on this range of opin-ion, we undertook a study to quantify the views and opinions of the leading 80 Pharmaceutical/Life Science HR teams to determine expected trends in the second half of 2011.

There was general agreement that things have improved since this time last year, with 71% of the respondents experiencing a growth in hiring in the first six months of 2011. On further examination of the skill-sets relating to this figure, we see more positive signs, giving more confidence in the areas mentioned. 12% said quality expanded, 24% named manufacturing but interestingly, R&D held at just 6%, while HR/IT/Finance came to 18% of the growth, sug-gesting a corporate openness to spending has returned. 18% of jobs were newly created positions, with 65% of the organisations questioned saying they had a mix of new and backfill roles.

Alarmingly, 41% of hiring professionals stated that the quality of candidates was the biggest barrier to recruitment this year to date. This leads to the question whether or not we have to change the recruitment models, style of hire, job functions or expectations of a new employee? Head count approval was consistently featured by 29% of the respond-ents. In support of these statistics, Berkley Pharmaceutical and Life Science can confirm an increase in the requests for market analysis for Senior Management, particularly in the area of skills availability and cost of hire, analysed on an international basis.

Progressive outlook for Q3 and Q4

Looking forward into Q3 and Q4 there is reasonable con-fidence that things will remain in a progressive state. 24% thought there would be a further increase in hiring, 35% thought it would decrease while 41% were unsure/not in a position to comment, due to reasons including the level of employees on long term leave, temp worker increases, no recruitment planned but things are in a changing and irregular pattern.

Interestingly, the areas most effected by any planned downsizing were QA, manu-facturing and capital projects. Our survey was based on the comments of those within the HR function, so further research into the availability of funding for capital projects will be conducted by Berkley Engineering later in the month. Manufacturing featured in the downsizing stakes at the top of the league table, but thankfully this should be balanced out by the growth planned in other organisations.

Broadening the skill Base

Candidate quality and availability, while it is listed as an area to improve by our industry leaders, it is also important to note that 71% of our audience have hired internationally this year. This statistic in isolation can be representative of the Irish R&D economy portrayed across the globe, but in factual terms, it gives rise to the question: do we have a broad enough skill base in the local market to serve the modern pharmaceutical and life science world with the changes in technology, manufacturing environment and typical hires? A major topic of discussion over the last few years has been the rise of upskilling programmes. One wel-comed, due to the focus on technology and interpersonal skills combined, is that of InnoPharma Labs.

Within Berkley Group’s European markets, we still see Ireland holding a steady pace against international trends, and we are encouraged with the amount of successful work being carried out by the IDA teams in Life Sciences, in the efforts to attract more quality FDI. In this arena, our Asian operations see the “on the ground” work carried out by the IDA internationally, and it has to be applauded.

23

recruitment

Growth: how and where It Is2011 looks to be brighter for recruitment in the pharmaceutical and Life Science sector, according to the results of a new study by Berkley Group, writes Joanna Houston, EMEA Operations

Manager, Berkley Pharmaceutical & Life Sciences, Engineering.

BERKLEY Group, consisting of Berkley Engineering, and Pharmaceutical & Life Sciences operates in Europe and Asia. They can be contacted at www.Berkley.ie Tel: 01-8724666 / 021 4289600.

25

Pharmaceutical Packaging

The Times They Are a-Changin’’ (Dylan, 1965): the theme song for Pharma in 2011? Never could a song capture the mood of

the current state of affairs in the pharma-ceutical industry like this one does.

The pharmaceutical landscape as we know it is changing. The industry’s desire to reduce cost, innovate and commercial-ise value-added products demands new approaches to how it makes and delivers drugs . The once indomitable pharmaceuti-cal giants have had to come to terms with the reality of no longer being able to rely on a pipeline of blockbuster brands to maintain their huge profits . The focus, it now seems, has switched to niche products, and the flexibility and capability to manufacture them.

What role, if any, can contract manu-facturing organisations (CMOs) play in this ‘Nouveau Pharma’ landscape? John Bolla (GSK) recently remarked, “There is a significant opportunity for contract manufacturers to help us and rationalise our manufacturing networks”. Indeed, for pharma companies big or small, outsourc-ing has always played a vital role – provid-ing opportunities to lower scale-up and manufacturing costs, increase flexibility in terms of manufacturing capacity and eliminate capital costs associated with the launch of, and continued market demand for product.

If we agree that CMOs have a vital role to play in the new pharmaceutical envi-ronmental – what role, if any, for a more specified branch of the CMO – the contract packaging organisation (CPO)?

Pascal Keogh, MD of Millmount Healthcare, explains how his company’s commercial business model is adapting to the demands of the modern pharma-

ceutical industry – small run / late-stage customisation.

How would you assess the current plight faced by many organisations operating in the pharmaceutical industry?The pharmaceutical industry is faced with more challenges than ever before – strict legislation in the form of governmental price controls, an apparent lack of new blockbuster candidates, personalised medicine and patent expiry, with increased competition in the form of new generic entrants. As a result, the market share for the existing companies is drastically being reduced. There are increasing demands for smaller run sizes. Subsequently, there is a major focus on inventory control and wast-age associated with short runs, regulatory change and short shelf-life products.

What challenges, if any, do these changes in the landscape have on companies such as Millmount Healthcare?The contract manufacturing industry is one of constant change. It suffers or ben-efits from the stresses and strains of the pharmaceutical industry. Consequently, Millmount Healthcare must be flexible, and where possible, anticipate our partners’ requirements in order to exceed all their expectations. This has meant us adapting several of our lines to facilitate short-run, quick turnarounds. We work with our customers to standardise on pack layouts, so that the cost of cutter profiles are kept to an absolute minimum. We are also working with our suppliers to ensure competitive-ness on short-runs.

As a company, we have had to stream-line our systems and procedures by intro-ducing LEAN practices. Our definition of a small run is probably 25% of what

One Small-Run fOR CPOS, One Giant leaP fOR PhaRma!

Pascal Keogh, MD of Millmount Healthcare, explains how utilising CMOs and CPOs as part of a long-term strategy can allow pharmaceutical

manufacturers to adapt to the demands of the modern pharmaceutical industry, while helping to cut costs.

Pascal Keogh, Managing Director, Millmount Healthcare.

“

Irelands only manufacturer of fibre drums

www.industrialpackaging.ie

Killarney Road, Bray, Co WicklowTelephone: +353 1 2864010 Fax: +353 1 2864015


Industrial Packaging Ltd.

Fibre Drums

Plastic Drums

IBCs

Security Tags & Seals

Small Sample Drums/Containers

Locall: 1890 440 440, email:[email protected], www.oflynnmedical.com

27

we would have considered a small run several years ago. Down-time reduction and rapid changeover times remain key factors for driving efficiencies in this model.

With cost becoming a critical deciding factor when choosing a contract packer, are you finding customers increasingly moving to non-European service providers?We are actually finding that the trend is starting to reverse. Although companies are still open to the idea of purchasing tablets/capsules from outside the European Union, there is a drive towards small scale / late-stage customisation within Europe. This allows them to closer match country-wide demand with bulk availability, with a typical conver-sion time from bulk to specific market livery within three weeks. It also means that analytical testing is reduced to testing on the bulk batch, as opposed to sub-batch testing for each market.

So what does this mean for generic manufacturing in Europe – are we seeing the beginning of a decline in this area?There are ample opportunities for growth in the gener-ics market, despite the fact that it is an extremely cost-conscious area. The market dynamics here focus on being first-to-market, with fierce competition, and fast attrition in market share.

I believe that we are seeing the beginning of a trend, whereby large-scale manufacturers are focusing on core competencies, whilst realising that outsourcing has the potential to deliver excellent business value, beyond simple cost savings and operational flexibility. They are breaking down production runs to large and small series and on the whole, are focusing on tablet manufacturing and large series runs internally, giving them extremely competitive costs of goods, while outsourcing the small series runs to companies better geared for this type of work.

Millmount Healthcare has the necessary systems in place, along with compatible machinery and tooling, to form a seamless extension to our partners’ current manu-facturing practices. Our partners can typically expect to enjoy reduced cycle times, costs and resources associated with packaging, while maintaining control of information.

What additional advice can you offer manufacturers to improve efficiencies and/or reduce cost?Despite specialising in packaging and warehousing solu-tions, we have on occasion been sought after for advice and counsel by our partner companies. We are happy to provide this service, and would look for a solution to their packaging problems on a case-by-case basis.

Pack lay-out is one area which can reduce the cost substantially. For example, 28 tablets in one blister typically cost half the price of two blisters of 14 tablets. Standardisation of pack design is another area which war-rants further examination, with the potential to speed up changeover, both on packaging lines and component sup-pliers, leading to cost benefits.

ConClusion

The pharmaceutical landscape is well and truly ‘a-Changin’, with manufacturers being forced to re-think their operations and as a result, transform their approach to outsourcing. Rather than meeting the changing land-scape with fear and trepidation, they must embrace the challenge and learn how best to build alliances with both CMOs and CPOs as part of a long-term strategy to allevi-ate their cost and R&D woes.

PharmaCeutiCal PaCkaging

About MillMount HeAltHcAre

EXPERTS in contract packaging operations, Millmount Healthcare provides an effective outsourc-ing strategy from 3 cGMP compliant, Irish Medicines Board (IMB) approved manufacturing facilities. Major pharmaceutical and healthcare manufacturers use Millmount Healthcare for their blister packaging, bottling and warehousing requirements to achieve high-quality results with lower overheads. The com-pany also acts as a European site of importation for non-EU products.

Millmount HealthcareBlock 7CityNorth Business CampusStamullen, County MeathTel: +353 (0)1 841 8300Fax: +353 (0)1 841 8039Web: www.millmounthealthcare.comTwitter: www.twitter.com/MillHealthcare

28

ReseaRch & Development

Pharmachemical Ireland would welcome the creation of a National Pharma Competence Centre, encompassing small and

large molecules. Our vision is one centre for the sector consisting of FDI’s and SME’s, harnessing all of the resources available in the HEI’s. A pharma competence cen-tre would assist the Irish pharma sites to become or maintain their position as the “site of choice” within their global site portfolio.

We live in challenging times and the sector is acutely aware of the specific chal-lenges it faces, including patent expiration, diminished volume from research pipelines and global consolidation. In order to combat these threats, PharmaChemical Ireland has identified five key research areas, which will provide opportunities for the industry to make Ireland a global pharma centre of excellence. A centre encompassing both biopharma and small molecule technologies would be unique globally and would closely mirror industry trends. The five key research areas identified include:

1. Biocatalysis / BiophaRma / chemistRy / GReen chemistRy

With eight out of the top 10 major international API com-panies having manufacturing facilities here, Ireland has

the potential to become a global leader in Biocatalysis technology, leveraging on skills acquired in biopharmaceutical and small molecule manufacturing. In addition, there is significant activity and capability within Ireland’s research institutes and SME’s, in this space. Biocatalysis is already taking place in some facilities, with the expecta-tion that it will increase as products from R&D groups progress towards launch stage. Biocatalysis presents Ireland with a great opportunity to lead in the area of green environmental sustainability.

2. continuous pRocessinG with moDellinG

The pharmaceutical industry in Ireland has largely evolved during a ‘Batch

Manufacturing Platform’ paradigm, resulting in most of our installed manufacturing facilities, technical support and regulation, being highly geared towards the batch based platforms. The industry is now moving towards ‘Continuous Processing Platforms’ that have proven suc-cessful in other industries, such as petrochemicals and fine chemicals. An Irish centre of excellence for continuous manufacturing, supporting the application of Continuous Manufacturing concepts into the Irish pharmaceutical industry, could enable the batch to continuous manufactur-ing paradigm shift to occur within our batch manufacturing sites for the next generation products.

3. pat/QBD with moDellinG

Current available technology can often be expensive and not robust to operate on an ongoing basis as process control. An interest in identifying/ developing alternative technology that is robust and less expensive is desirable. Graduates are not presently knowledgeable or skilled in the area of QbD and specifically in DOE - this is a gap that needs to be addressed. There may also be a lack of skill / expertise amongst graduates in data modelling.

The development of this expertise has a number of potential applications in gathering process data and using

Towards a NaTioNal Pharma ComPeTeNCe CeNTre

PharmaChemical Ireland has identified five key research areas, which will provide opportunities for the industry to make Ireland a global pharma centre of excellence, writes Nessa Moyles, Senior Executive,

PharmaChemical Ireland.

BiotechnoloGy

that data to predict performance, in addition to making processes more predictable and in the scale up from lab/ kilo to manufacturing.

A centre of excellence that would carry out “proof of concept” would be of value to participating companies, in addition to providing training and support to improve knowledge and capability within companies. Crucially, the centre could enable graduates to become knowledge-able and experienced in the application of PAT and data modelling.

4. soliD state phaRmaceuticals

Ireland could host a critical mass of expertise and research programs in a Solid State processing centre of excellence, aimed at adding value and development of new products. It would enable second generation chemistry on new chemi-cal entities and make processes more robust. In addition, it could drive down manufacturing cost and extend product lifecycle with formulation development approaches. The centre would, of course, leverage from existing infrastruc-ture in Ireland (such as the Solid State Pharmaceutical Cluster based in UL) and connect with existing centres in the UK (Strathclyde, Newcastle and Leeds) and further afield.

5. analysis

Research and innovation facilities involving specialist analytical services, next generation HPLC analysis, mass spectroscopy and bioanalysis will support plans for the pharma industry to move up the value chain and focus more on the higher value tasks, for example, R&D, clini-cal supply, product launch and second generation process development. In such instances, cutting edge analytical technology will be required to ensure those tasks can be supported in this country.

An analytical centre of excellence can provide this support in multiple ways - by providing the industry with the services and by training graduates in the higher level analytical skill sets that industry can then hire directly. A

QbD centre of excellence with supporting analytical capa-bilities would have global recognition (best practice on how to perform QbD and apply LEAN methods to research).

playinG to ouR stRenGths

PharmaChemical Ireland views the establishment of such a centre as critical infrastructure which will play to our key strengths:

• A unique concentration of world leading manufactur-ing;

• World class facilities in universities and IT’s;• A critical volume of talented PI’s and Post Docs in our

HEA facilities;• A good volume of SME’s with an excellent track

record;• A strong willingness to work together across compa-

nies, academia and Government.PharmaChemical Ireland has identified research being

carried out at present in Ireland under all five headings, in addition to indigenous Irish companies working in this space, all of which, combined with such an infrastructure, will best position the Irish pharma industry for the chal-lenges ahead and maximise success for the future.

The Pharma-chemical sector in Ireland is critical to the success of the Irish economy:• Eight of the top 10 multinational companies in the

world have substantial operations in Ireland;• The replacement value of the sector is estimated to be

€40 billion;• €350m investment on capital projects over the past

12-18 months; • Recent investments range from plant upgrades to new

Greenfield facilities;• 25,400 employed directly, with the same number

employed indirectly;• €47.2 billion exports (2009);• €1 billion per year in corporation tax contribution.

29

ReseaRch & Development

IRISH Lift Trucks, the exclusive distributor for Hyster materials handling equipment in Ireland, has announced several new developments to its range of Hyster warehouse equipment, delivering a low cost

of operation and dependable, energy efficient performance for demanding operations.

Low LeveL order Pickers

The new LO2.0-2.5 low level order picker from Hyster has been developed to optimise the speed and ease of picking from both sides of a warehouse aisle. The intelligent design combines energy efficiency, reliability and ergonomics to achieve excellent operator pick rates and low cost of operation.

One of the most notable design elements is the ‘man to goods’ proximity and the comfortable work platform with reduced height that helps minimise movement and saves valuable time in the picking operation. The large platform provides more space and allows easier pass-through with easy on/off access.

HigH LeveL order Pickers

The Hyster K series of rising cab order pickers is designed to allow the best use of warehouse space and maximise pick face access at medium and high locations. The K series may be guided or non-guided: however, guided travel (rails or wire guidance) allows simultaneous lift and horizontal movement.

vNA

Hyster very narrow aisle (VNA) trucks enable operators to optimise storage capacity and efficiently retrieve pallets in high intensity operations. Horizontal movement intel-

ligently combines with vertical movements to ensure one of the quickest VNA transits in the industry. Common features include integral pantograph on the turret head and patented QUAD form mast design, which provides unmatched rigidity and torsional strength.

reAcH Trucks

In April 2011, Hyster announced changes to its Matrix reach truck series, including an increase in maximum traction speed of 8%. With no change between laden and unladen speeds, Hyster has achieved faster cycle times, especially over long distances, helping to reduce the cost of operation.

Hyster Intelligent Design provides ease of control, giving superb narrow aisle manoeuvrability. It features 180° or 360° progressive steering, powerful acceleration and braking torque, seamless change in travel direction and automatic speed reduction on cornering. Hyster has also redesigned the overhead guard to optimise visibility and the series features a new full suspension seat.

PALLeT, sTAcker ANd Tow Trucks

A complete range of Hyster pallet trucks and stacker trucks deliver reliability, power and precision, enhancing the operator’s productivity when transporting, stacking or de-stacking with a low cost of operation. Hyster has also introduced a tow truck to its range, which is suitable for supplying material to production lines, making it ideal for any type of line feed operation.

eLecTric couNTerbALANce

The JXN(T) series of three and four wheel electric coun-terbalance trucks delivers class leading manoeuvrability

30

MATeriALs HANdLiNg

Hyster ForkliFts Develops range

Irish Lift Trucks has announced a host of new developments to its range of Hyster forlklifts and warehouse equipment.

› New & Used Forklift Sales › Rental › Service › Parts › Training

Loads more efficiency

Call: 01 403 4100 | www.irishlifttrucks.ie

Irish Lift TrucksClonlara Avenue, Baldonnell Business Park, Baldonnell, Dublin 22, Ireland.T. (+353) 01 4034158 F. (+353) 01 4034183 E. [email protected] www.ohm.ie

A member of

and the best balance of energy efficiency and productivity to suit demanding applications, with exceptionally low maintenance requirements. Lift capacities start at 1.5 tonnes and Hyster has recently extended the range to include 4-5 tonne capacities.

OptiOns and ExplOsiOn prOtEctiOn

Hyster equipment is available in a range of options and configurations to suit specific applications. As some phar-maceutical facilities operate with classified hazardous areas, Hyster equipment can be supplied with Pyroban protection to ATEX 94/9/EC and supported by fully trained engineers.

In short, ILT supplies the most complete forklift avail-able on the Irish market today renowned for reliability, performance and helping reduce operating costs. The prod-uct range includes diesel, gas and electric Counterbalance forklift trucks, manufactured in Ireland, as well as warehouse equipment including Powered Pallet Trucks, Order Pickers, Reach Trucks and VNA Equipment, large capacity forklift trucks and containers handling equip-ment. They offer nationwide service support and all makes replacement part availability, as well as short term and long

term rental packages for new and used trucks, professional advice on fleet management and warehouse design and a comprehensive range of training courses for all materials handling equipment.

Fore more information, see www.irishlifttrucks.ie.

MatErials Handling

32

Sustainable and Cost-effective Waste ManagementIndaver’s trademark is delivering fast, effi cient and

cost effective services in the specialist hazardous

and non-hazardous waste market.

■ Hazardous Waste Management

■ Total On Site Waste Management

■ Solvent Recovery

■ Disposal of Laboratory Chemicals

[email protected] Tel. +353 1 280 4534

www.indaver.ie

CHEMICAL Dis tr ibut ion Ireland (CDI), formerly the Irish Chemical Marketers Association, was established

in 1994. CDI is affiliated to IBEC and is a member of the FECC, the European Association of Chemical Distributors. CDI is the leading representative body for the chemical distribution industry in Ireland. Membership of CDI demonstrates the member company’s commitment to best practice in chemical distribution and ongo-ing responsibility in areas of product stew-ardship, safety, environment and quality. Members of CDI work to provide secure supply chains from producers to users and act as a valuable partner for material sourcing, storage and delivery.

The main aim of CDI is to promote, support and encourage the further devel-opment of the multinational and indigenous chemical sector in Ireland. CDI achieves this by building and maintaining excellent relations and a positive profile with Government, public agencies, other representative organisations, inter-national bodies and other interested parties.

Independent AudIts

The Responsible Care Working Group was one of the first to be established, following the formation of the asso-ciation. It set up a number of minimum standards which members were required to meet as part of their conditions of membership. However, it was not until it reached an agreement with PharmaChemical Ireland (PCI) and the European Chemical Industry Council (CEFIC) on the use of the Responsible Care trademark and logo that the work began.

It was recognised at an early stage that a mandatory system of independent audits, to be assessed and based on requirement of continuous improvement, would be needed to give the program credibility. In 1999, all members underwent a Phase I audit (SQAS ESAD I) which was accredited by the national employers body, IBEC. In 2007, preparation began for a Phase II audit (SQAS ESAD II) which was carried out by an independent auditing author-ity. Each member company delegates a Responsible Care coordinator to attend meetings.

ResponsIble CARe

CDI members follow the guiding principles of Responsible Care (using the assessment tool SQAS Distributor ESAD). These assessments are mandatory for membership. SQAS Distributor ESAD is a document developed jointly by chemical suppliers and distributors for use in one single assessment of distributors. It includes health, safety, environmental and quality aspects. There are also sections which cover the principles of GTDP (Good Trade & Distribution Practice). Trained assessors conduct assess-ments. Associate members, who are service providers to CDI members in the area of warehousing and transport, are required to undergo a relevant SQAS assessment such as SQAS Transport or SQAS Warehousing.

CDI members must sign up to the eight guiding principles of Responsible Care: • Legal Requirements• Management of Risk• Policies and Documentation• Provision of Information• Training• Emergency Response• Ongoing Improvements• Community Interaction

“Responsible Care is the chemical industry’s own, unique initiative - a voluntary programme that helps it to raise its standards and win greater trust from the public. Under Responsible Care, the worldwide chemical indus-try is committed to continual improvement in all aspects of health, safety and environmental performance and to open communication about its activities and achieve-ments. Responsible Care is more than a set of principles and declarations. Through the sharing of information and a rigorous system of checklists, performance indicators and verification procedures, it enables the industry to demonstrate how it has improved over the years and to develop policies for further improvement. In these ways, Responsible Care helps the industry to gain the trust of the public and to operate safely, profitably and with due care for future generations” - CEFIC. For more information, see www.chemicaldistributionireland.ie

33

ChemICAl dIstR Ibut Ion IRelAnd

Promoting Best Practice

Nessa Moyles, Director, Chemical Distribution Ireland, explains the work of Chemical Distribution Ireland in the realm of industry

best practice and responsible care.

34

Live events

Are you a nervous person? Give the following scenar-

ios a mark out of 10 regarding how nervous you would be

in these situations, with 0 being totally confident and 10 being the most nervous you could be. I’ll put my own scores and thoughts down so you can see how we stack up against each other.

1) You are tasked with organising a small graphic dis-play the size of an ice cream van in your company reception.

That’s easy. It’s what I get paid for, no need for nerves. Just need to understand the key objectives of the display and make sure it’s “punchy” and to the point - 1/10.

2) The small display has been upgraded to a large con-ference area the size of a tennis court in a local hotel.

That’s changed things a little but still no great problem. I need to find out the exact space and the location with-in the main hall so I can maximise my impact – 3/10.

3) There needs to be refreshments supplied for everyone at the event. Interesting! Refreshments aren’t really my thing but how difficult can it be to order some coffee and cookies? I’ll get some top quality refreshments in to really hammer home the quality of our brand – 4/10.

4) You need plasma screens running your corporate presentations too and internet access.

You’re not the IT person but all they would suggest is switch it off and switch it back on again. It will be a great opportunity to get our new information out there on the plasma screens – 5/10.

5) All of your own company employees are going to be there.

Wowzers! That’s going to be tough, but at least they’re all on my side and will be wishing me well…..well apart from Sophie in Human Resources who has had it in for me since the Christmas party 2009 for obvious reasons – 6/10.

6) All of your competitors are going to be there with their own presentation and you know that they will all have pushed the boat out.

Ah, now that’s really stepped it up a notch! Let’s take the opportunity to hammer home our own USPs and really let people see that we can offer extra benefits over the competi-tion – 8/10.

7) And all of your potential clients and pros-pects will turn up too to judge you directly against every other company in the room.

Right then! This is where I really earn my money. I need to remember that we’ve got nothing to be afraid of. It’s the competition who should be nervous putting themselves up against us. Having said that, the nerves are inevitable – 9/10.

If the above scenario sounds familiar, then you must be responsible for organising some of your company’s live events and therefore, I

MaxiMise The iMpacT of Your Live evenTs

Paul Smith, Irish Sales Manager, Clip Exhibition and Display, explains how his company can take the stress out of organising live events.

A large percentage of Clip Exhibition and Display’s business comes from eight of the top 10 pharmaceutical companies in Ireland.

35

think you’ll agree that organising them is a tough job! To be honest, it’s a pressure that very few other roles

in your company will have. Other roles are tough, of course, and bring their own pressures but live events are just that…..LIVE. When the doors open and the visitors walk through the door, there’s no chance to hit the pause button and make any changes. There’s no “version 3” or next draft. It’s lights, camera and action!

30 Years of exhibition stand buiLding experience

I know the stresses and strains of exhibiting well, as I work for Clip Ireland, part of the Clip International group. With offices in Ireland, Germany, Belgium, UK and a world-wide distributor network, Clip have been at the forefront of the European exhibition and display business for over 30 years.

We have built our reputation by taking pride in high quality standards, understanding our clients’ exhibition and display needs, and continuously aiming to exceed expectations. Our pedigree and commitment is there for all to see in the exhibition stands that we create today. We employ over 50 staff members in our UK and Irish opera-tions. In 2010 alone, we built over 600 stands in venues from the RDS to Cape Town, from the Maldron Hotel, Killarney, to Dubai: we understand the stresses and strain of exhibiting and it is our job to take those stresses away from you.

Leaders in the irish exhibition MarketpLace

As Europe’s leading exhibition and display manufacturer, we are constantly developing and improving our innovative product range. As all products and services are handled ‘in house’, we can maintain strict control over production and quality. We are proud to offer a total one-stop-shop solution, from portable kits and graphics to large stands and hire, and because we handle every part of the process in-house, we can guarantee that whatever your require-ments, it will be problem free.

An office was set up here in Ireland in 2004, in order to cope with the huge demand for our products and services from a range of Irish based companies. Our Irish business has grown and developed every year since 2004, and we are proud to have worked with over 3,500 different compa-nies in Ireland, ranging from multinational pharmaceutical suppliers to hotel chains, shopping centres, Government bodies and agencies, sports organisations and many more.

suppLier to eight of the top 10 irish pharMaceuticaL coMpanies

A large percentage of our business comes from eight of the top 10 pharmaceutical companies in Ireland. We pro-vide a range of products and services to these companies, including a wide selection of display products, as well as designing and building various exhibition stands, both here in Ireland and across Europe. Many of these companies

have worked with Clip Ireland for many years, and they utilise various services we can offer, such as Stand and Graphic Design, Build and Breakdown of Stands, Storage and Transportation of Stands/Display Products and Hire of Various Stand Components, as required.

Next time you have a live event or exhibition, please get in touch to help us take away the stress and strain of the event. In brief, we can help in every way:

• Understand your exact event objectives to ensure that we help you maximise your pre-show marketing;

• Help set the measurable objectives for the event, to ensure you maximise the return on your investment;

• Our free stand design service will ensure that the physi-cal elements of your brief are met;

• Give stand manning training so that your staff know how the stand needs to be run to get the most out of it;

• Help you manage your post-show follow-up, to make sure you have the return on investment that you were looking for;

• Use our network of worldwide subsidiaries and dis-tributors so that wherever your event is taking place, we are your local stand contractors;

• Make use of the most modular and versatile exhibi-tion stand system on the market. A system likened to “adult Lego” that can be reconfigured for all of your live events, giving you maximum return on investment and minimum on cost. The more events you attend, the cheaper the system becomes.

Live events

As Europe’s leading exhibition and display manufacturer, Clip are constantly developing and improving their

innovative product range.

For more information please contact us on Freephone 1800 303438 or email [email protected]. Alternatively

please visit our website at www.clipdisplay.ie.

ww

w.p

rosys.iew

ww

.pro

sys.

ie Pharmaceutical, Biopharma & Nuclear

Process Containment Isolators

Laboratory scale to Small scale to Production scale

ChargingDispensingOff-LoadingFillingSeedingSamplingContainedProcess

T/F: 067 37893 087 [email protected] www.goliath.ie

BEECHWOOD, NENAGH, CO. TIPPERARY

Erecting

Case Packing

Bag-in-Box

Sealing

Conveying

Lifting

Inverting

Palletising

Wrapping

Strapping

AGV Transport

Washing Systems

sales � installation � service

ProSys Containment & Sampling Technology specialise in the design and manufacture of both Positive and Negative Pressure Containment

Isolators, Gloveboxes, Downflow Booths, Restricted Access Barrier systems (RABs) and sampling solutions to meet the ever changing require-ments of the pharmaceutical indus-try. Their products include both standard and custom engineered containment solutions.

The company was founded in 1997 to supply specialised sampling solutions to the pharmaceutical industry. Over the last five years, ProSys has expanded rapidly by designing and devel-oping a range of Containment Isolators. Their vision is to be the ‘Preferred Supplier’ of Custom Containment Equipment to the global pharmaceutical production industry.

New MaNufacturiNg facility

The company headquarters is based in Cork, placing it in a cen-tral cluster of top pharmaceutical global players, such as Pfizer, GSK, Novartis, Janssen, Lilly etc. A new manufacturing factory is currently under construction at the IDA Industrial Park in Carrigtwohill, Co. Cork, which will include a dedicated clean room.

ProSys currently has sales offices in Liverpool (UK), Lille (France) and New Jersey (USA) and expects to open an office in Germany later this year.

coNtaiNiNg Hazards at source

Their philosophy is to contain any hazard at source, minimise cleaning, maximise flexibility and maintain an environment that is safe for all personnel. Depending on the appli-cation, the optimum solution will be achieved by the use of primary and secondary containment strategies or by combining a number of different techniques and technologies.

All of their designs have been fully tested and qualified to contain potentially hazardous material to extremely low Operator Exposure Levels (OELs), whilst still retaining the flexibility that is required by the end user.

ProSys Containment and Sampling technology provide complete turnkey solutions from initial Concept Design to In-house Manufacture and Functional and Containment Testing to On-site Qualification, Operator Training and Maintenance.

cost of owNersHip

Life Cycle Cost Analysis allows ProSys to examine costs from inception to con-clusion and to offer different design making alternatives to achieve the lowest cost of ownership.

Indeed, ProSys recently completed a containment project for a secondary pro-duction facility that involved designing an isolator around an existing encapsulator machine. A team of client engineers and operators travelled from the USA to carry out ergonomic trials, then design review and finally FAT with OEL testing. The project included moving and re-wiring the electrical control centre, while maintaining the original integrity of the mechanical encapsulator machine. The end result: the owner saved $1m by choosing to upgrade rather than purchasing a new machine.

37

coNtaiNMeNt tecHNology

Containing Hazards at sourCe

ProSys is on course to become the preferred supplier of Custom Containment Equipment to the pharmaceutical production industry worldwide.

See www.prosys.ie for more information.

• Cartons• Leaflets• Labels• Printed foils for blister packs

Contego PackagingUnit 629, IDA Industrial Park, Northern ExtensionOld Kilmeaden Road, Waterford, Ireland

Please contact Maria Moran Business Development Manager

T +353 (0) 51 595300 M +353 (0) 87 9885913

Innovative packaging solutions for the pharmaceutical and healthcare industries

www.contegopackaging.com

Following the recent acquisition of Nampak Paper Holdings Limited by Platinum Equity, a

rebranding exercise has resulted in a new name and identity for the busi-ness. Since June 1, 2011, the com-pany has been renamed Contego Packaging.

Contego is the Latin word to ‘protect, shield, cover and defend’, mirroring the company’s com-mitment to supplying customers with high quality packaging for their products. A pan-European campaign is currently underway to roll out the new name, encom-passing everything from signage to stationery.

A New erA

“Our new name and identity mark the beginning of a very exciting era for our business,” explained Tom Reid, Chief Executive Officer, Contego Packaging. “We have already made some significant announcements regarding investment in plant and technol-ogy, including a new facility that will replace and upgrade our current factory in Portsmouth, which is scheduled to be fully functional by the end of 2011. Further develop-ments are also in the pipeline for investment and improve-ment at our sites across Europe.

“As ever, our commitment to providing our customers with the highest quality products and service remains top of our agenda”.

Contego Packaging supplies the pharmaceutical indus-try with cartons, leaflets, labels and blister pack foils from 10 sites across Europe.

LeAfLets

One of Contego Packaging’s print facilities for leaflets for the pharmaceutical and healthcare industries is located in Waterford, where state-of-the-art printing and folding technology provides accurately folded, high quality leaflets

for pack insertion on high speed lines.

Leaflets are printed on offset litho presses and supplied to customers flat, folded or cross-folded. Folding is determined by customer specification and pack size; the folded leaflet is suitable for high volume batches, whereas the flat option allows for smaller quantities.

CArtoNs

In addition to leaflets, Waterford also produces over 200 million high quality cartons each year in a wide range of styles, construc-tional designs and graphical print finishes, onto different substrates and thickness of material. There is also the facility to provide performance varnishes, security and tamper-evident features and Braille embossing.

The latest computer-to-plate technology is used in the prepress process, ensuring the highest

quality print, with their stringent quality system, ISO 9001:2008 delivering 100% control from origination to final production.

ProduCt PortfoLio

Working in conjunction with customers and with other Contego sites located across Europe, a comprehensive range of self-adhesive labels and foils for blister packs can be supplied to complement leaflets and cartons produced at Waterford. Supply solutions can also be delivered to meet individual requirements, including supply chain manage-ment and Just-In-Time deliveries.

39

PACkAgiNg

The CompleTe paCkage

Contego Packaging supplies the pharmaceutical industry with cartons, leaflets, labels and blister pack foils from 10 sites across

Europe, including their plant in Waterford.

For further information, please contact Maria Moran, Business Development Manager, Contego Healthcare

Waterford, tel: +353 51 595300, mobile: +353 87 9885913Email: [email protected]

SUPPLIERS OF:

MEMBERS WORKING FOR THE ENVIRONMENT

WE OFFER A WIDE RANGE OF CHEMICALS, SOLVENTS AND SPECIALITIES FROM REPUTABLE PRODUCERS

A LARGE RANGE OF MATERIALS CAN BE SOURCED TO YOUR SPECIFICATION

Whatever your requirement please contact: Carol Deegan Carbon Group, Ringaskiddy, Cork

Mobile: 086 2612 485Fax: 01 628 9379

Email: [email protected]: [email protected]

Website: www.carbon.ie

ACETATE ESTERSACIDS & ALKALISANTIFREEZE / GLYCOLSBLENDING - LIQUID/DRYCIP DETERGENTSCONSUMABLESCONTAINMENT PACKAGINGETHANOL

ETHANOLAMINESEXCIPIENTSFATS & WAXESFRAGRANCES & FLAVOURSGLYCOL ETHERS / ESTERSGLYMESHYDROCARBON SOLVENTSKETONES

LABORATORY CHEMICALSPETROLEUM JELLIES / WHITE OILSPHARMACEUTICAL SPECIALITIESPOLYETHYLENE GLYCOLSSALT - ALL GRADESSOLVENTS

• Temporary or longer term hire• 4 pallet to 39 pallet capacity• Single or dual refrigeration system• -40°c to +50°c temperature range• Door options available• Ground level or loading bay level• Can be sited inside or outside• Upgrade Facility

Purpose Built Cold Stores offering Flexibility and Reliability

Dawsonrentals Ireland Ltd.Unit 20, Toughers Business Park, Newhall, Naas, County Kildare

Tel: 045 448810

Email: [email protected] Web: www.dawsongroup.co.uk

Dawsonrentals | temperature control solutions

Everybody strives to improve operational effi-ciency: Dawsonrentals Ireland can provide the cold storage flexibility that allows you to react promptly in a constantly changing business

environment.Dawsonrentals pride themselves on their ability to

listen, understand their customers’ wishes and provide a solution that makes their business more effective and therefore more profitable.

“We understand the importance of improving your operation and now do so much more than simply off-load a unit and leave,” explains Aidan McCauley, Dawsonrentals. “Whilst we will supply a stand alone product, if that’s what is right for our customer, we are increasingly linking units and/or attaching units to the customer’s existing premises. The key is not the unit itself, but how it works for the customer.”

Design & innovation

The growth in design and innovation can be attributed to the infrastructure of ‘Team Dawson’, which includes both Project and Technical teams. “This is why we are able to deliver a solution with the characteristics and feel of a permanent facility,” McCauley continues.

Dawsonrentals’ overall focus is on providing high quality, premium products and while some rental compa-nies may only provide a set range of equipment for hire,

Dawsonrentals will always engineer their product to suit each individual customer’s needs. “In short, customers can look to Dawsonrentals for a tailored product which is sup-ported by a premium service,” says McCauley.

Case stuDy

Diversification for many companies is difficult, especially when there is the added need for large capital expendi-ture. A leading pharmaceutical provider successfully overcame these challenges by dramatically expanding their cold storage.

The pharmaceutical company wanted to capture what they recognised to be an increasing business sector. A mod-ular storage complex was supplied. The facility enabled them to double stack and rack stock, thereby providing twice the amount of storage space. Dawsonrentals’ units easily achieved strict -2 to +8°C chilled MRHA/FDA vali-dated standards. Indeed, the customer’s continued success and demand from their growing customer base led them to request another duplicate complex, providing over 850m² of additional chilled storage space on site.

Absorbing the costs of the facility into revenue, the pharmaceutical company were able to support the effective solution without a high capital investment. Furthermore, each facility was built, delivered, installed and subse-quently serviced by Dawsonrentals.

Dawsonrentals Ireland is part of Dawsongroup. Dawsongroup services include the rental, lease and contract hire of: trucks and trailers, temperature control solutions; buses, coaches and accessible vehicles; forklift trucks/materials handling equip-ment; industrial and municipal sweepers; display refrigeration and cold rooms; temporary kitchens and production facilities; as well as the provision of asset finance and leasing brokerage.

For more information, contact:Aidan McCauleyDawsonrentals IrelandUnit 20,Toughers Business Park, Newhall, Naas, County Kildare.Tel: (045) [email protected]

41

Portable ColD storage

The Bigger Chill

Dawsonrentals Ireland offers high quality, flexible cold storage solutions, tailored to clients’ individual needs.

IrIsh PharmaChem 2011

42

aCIds & alkalIs

Associated Chemicals LtdBrenntag IrelandCamida LtdCarbon GroupChemco Ireland LtdChemsource Industrial DivisionCorcoran Chemicals LtdFisher ScientificGoulding Chemicals LtdNational Chemical Co. LtdOcon Chemicals Ltd P.K. Chemicals LtdSciChem - CorkSciChem - DublinUnivar Ltd

BIoChemICals

Associated Chemicals LtdCamida LtdCorcoran Chemicals LtdFisher ScientificOcon Chemicals Ltd

BIoCIdes

Brenntag IrelandCamida LtdFisher ScientificUnivar Ltd

Catalysts

Associated Chemicals LtdBrenntag IrelandCamida LtdChemsource Industrial Division Corcoran Chemicals LtdNational Chemical Co. LtdP.K. Chemicals Ltd

ChIral ComPounds

Associated Chemicals Ltd Brenntag IrelandCamida LtdWaters Chromatography Ireland

exCIPIents

Associated Chemicals LtdBetco Marketing LtdBrenntag IrelandCamida LtdCarbon GroupChemsource Industrial Division Corcoran Chemicals LtdNational Chemical Co. LtdOcon Chemicals Ltd P.K. Chemicals LtdUnivar Ltd

FIne ChemICals

Betco Marketing LtdBrenntag IrelandCamida LtdCarbon GroupChemco Ireland LtdChemsource Industrial Division Fisher ScientificNational Chemical Co. LtdP.K. Chemicals LtdUnivar Ltd

Gases

Corcoran Chemicals Ltd

heteroCyClICs

Brenntag IrelandCamida LtdNational Chemical Co. Ltd

InorGanIC ChemICals

Associated Chemicals LtdBrenntag IrelandCamida LtdChemco Ireland LtdChemsource Industrial Division Corcoran Chemicals LtdFisher ScientificGoulding Chemicals LtdNational Chemical Co. LtdOcon Chemicals Ltd P.K. Chemicals Ltd

SciChem - CorkSciChem - DublinUnivar Ltd

laBoratory reaGeants

Brenntag IrelandCarbon GroupFisher ScientificNational Chemical Co. LtdOcon Chemicals LtdSciChem - CorkSciChem - DublinWaters Chromatography Ireland

mIsC. ChemICals

Associated Chemicals LtdBrenntag IrelandCamida LtdCarbon GroupChemco Ireland LtdChemsource Industrial Division Corcoran Chemicals LtdFisher ScientificNational Chemical Co. LtdP.K. Chemicals LtdOcon Chemicals Ltd SciChem - CorkSciChem - DublinUnivar Ltd

oIls, Fats and Waxes

Associated Chemicals LtdBrenntag IrelandCarbon GroupCorcoran Chemicals LtdLister Machine Tools LtdNational Chemical Co. LtdP.K. Chemicals LtdUnivar Ltd

orGanIC IntermedIates

Associated Chemicals LtdBrenntag IrelandCamida LtdChemco Ireland LtdChemsource Industrial Division

ChemICal suPPlIers

Ch

em

ICa

l su

PP

lIe

rs


43

Corcoran Chemicals LtdFisher ScientificNational Chemical Co. LtdUnivar Ltd

orGanometallICs

Associated Chemicals LtdBrenntag IrelandCamida LtdNational Chemical Co. Ltd

reaGents

Associated Chemicals Ltd Brenntag IrelandCamida LtdCarbon GroupChemco Ireland LtdCorcoran Chemicals LtdFisher ScientificNational Chemical Co. Ltd

Ocon Chemicals LtdSciChem - CorkSciChem - DublinUnivar LtdWaters Chromatography Ireland

sIlanes

Camida LtdChemco Ireland LtdNational Chemical Co. LtdP.K. Chemicals Ltd SciChem - CorkSciChem - DublinUnivar Ltd

solvents

Brenntag IrelandCamida LtdCarbon Group Chemco Ireland Ltd

Chemsource Industrial Division Corcoran Chemicals LtdFisher ScientificNational Chemical Co. LtdOcon Chemicals Ltd SciChem - CorkSciChem - DublinSoltec (Ireland) Ltd Univar Ltd Waters Chromatography Ireland

surFaCtants

Associated Chemicals LtdBrenntag IrelandCamida LtdCarbon GroupCorcoran Chemicals Ltd National Chemical Co. LtdUnivar Ltd

Notes

Ch

em

ICa

l s

uP

Pl

Ier

s


44

aCtuators

AirpowerFesto LtdFlexachem Manufacturing LtdNorgren Ireland LtdPetrochem Pipeline Supply LtdTyco Valves & Controls Ireland Ltd

aerators

Manotherm LtdWrenTech Ltd

agItators

CPI Technology Ltd Fisher ScientificFlexachem Manufacturing LtdQuitmann O’Neill Packaging LtdWrenTech Ltd

aIr FIltratIon/monItorIng

/ PollutIon Control

Airpower Enva Ireland Ltd Norgren Ireland LtdOcon Chemicals Ltd SciChem - CorkSciChem - Dublin

alarms

P.J. Boner & Co. Ltd

analysIs servICes

AnectoCatalent Pharma SolutionsEnva Ireland Ltd Lancaster Laboratories

analytICal equIPment

P.J. Boner & Co. LtdFisher ScientificPetrochem Pipeline Supply LtdPPD Inc.

Sartorius Mechatronics LtdSciChem - CorkSciChem - DublinWeber Labelling & Coding

autoClaves

Fisher ScientificGoliath Packaging Systems LtdOcon Chemicals Ltd SciChem - CorkSciChem - DublinWrenTech Ltd

automatIon

Airpower P.J. Boner & Co. LtdBosch Rexroth LtdCallaghan Engineering Festo LtdFlexachem Manufacturing LtdGoliath Packaging Systems LtdNorgren Ireland LtdO’Flynn Medical LtdPilz IrelandWeber Labelling & Coding

BalanCes

P.J. Boner & Co. LtdFisher ScientificIrish National Accreditation BoardOcon Chemicals LtdSartorius Mechatronics LtdSciChem - CorkSciChem - DublinWrenTech Ltd

BarCodIng/laBellIng/traCeaBIlIty

Airpower Flexachem Manufacturing LtdGoliath Packaging Systems LtdGS1 IrelandMillmount Healthcare

BarrIers saFety

WrenTech Ltd

BIoteChnology

Brenntag IrelandCallaghan Engineering Catalent Pharma SolutionsFlexachem Manufacturing LtdH.R. Holfeld (Engineering) LtdOcon Chemicals Ltd SciChem - CorkSciChem - DublinWaters Chromatography Ireland

Blenders

Fisher ScientificFlexachem Manufacturing LtdSciChem - CorkSciChem - DublinWrenTech Ltd

BlIsterIng / de-BlIsterIng

Catalent Pharma Solutions

Blowers

Airpower CPI Technology Ltd Flexachem Manufacturing Ltd

BPrvBS&B Safety Systems Ltd

BurstIng / ruPture dIsCs

BS&B Safety Systems LtdCPI Technology Ltd Flexachem Manufacturing Ltd

general suPPlIers

ge

ne

ra

l su

PP

lIe

rs


45

CaBInets

Airpower Cross Technical SolutionsFesto LtdFisher ScientificProSys Containment and Sampling TechnologySartorius Mechatronics LtdWrenTech Ltd

CadCallaghan EngineeringWaters Chromatography Ireland

CalIBratIon

P.J. Boner & Co. LtdDalkiaIrish National Accreditation BoardOcon Chemicals LtdSartorius Mechatronics LtdWaters Chromatography Ireland

CentrIFuges

CPI Technology Ltd Enva Ireland Ltd Fisher ScientificSartorius Mechatronics LtdSciChem - CorkSciChem - Dublin

ChemICal Consultants

Carbon Goup Hazchem Training LtdPilz IrelandSoltec (Ireland) Ltd

ChromotograPhy

Carbon GoupFisher ScientificOcon Chemicals LtdSciChem - CorkSciChem - DublinWaters Chromatography Ireland

Cleanrooms

Callaghan Engineering Carbon GoupMillmount HealthcarePilz IrelandWrenTech Ltd

ClInICal reasearCh organIsatIon

HRB Clinical Research FacilityJava Clinical Research Ltd

CleanIng servICes /equIPment

Goliath Packaging Systems LtdWrenTech Ltd

Cold ChaIn PaCkagIng

Catalent Pharma SolutionsCRS Mobile Cold StorageMillmount Healthcare

ComPressed aIr/ComPressors

Airpower Cross Technical SolutionsFesto LtdNorgren Ireland Ltd

Condensors

CPI Technology Ltd Cross Technical SolutionsGraham Hart (Process Technology) Ltd

CondItIon monItorIng

P.J. Boner & Co. LtdCPI Technology Ltd Flexachem Manufacturing LtdDalkia

ConstruCtIon management

Callaghan Engineering

Conveyors

Bosch Rexroth LtdFlexachem Manufacturing LtdGoliath Packaging Systems LtdWeber Labelling & CodingWrenTech Ltd

CoolIng systems

CPI Technology Ltd Cross Technical SolutionsDalkia Dawsonrentals Irl Ltd

data aCquIsItIon

P.J. Boner & Co. LtdGS1 Ireland Manotherm LtdWaters Chromatography IrelandWeber Labelling & Coding

desIgn

Callaghan Engineering Cross Technical SolutionsGraham Hart (Process Technology) Ltd Pilz IrelandProSys Containment and Sampling Technology

dIsPersers

Ocon Chemicals LtdWrenTech Ltd

dIstIllatIon

CPI Technology Ltd Flexachem Manufacturing Ltd Graham Hart (Process Technology) Ltd Ocon Chemicals Ltd Soltec (Ireland) LtdWrenTech Ltd

draIns

AirpowerH.R. Holfeld (Engineering) Ltd

ge

ne

ra

l s

uP

Pl

Ier

s


46

drIers

Airpower Complas Packaging LtdCPI Technology Ltd WrenTech Ltd

drums/ContaIners

Carbon GoupChemsource Industrial Division Complas Packaging LtdIndaver IrelandIndustrial Packaging LtdInterpacOcon Chemicals Ltd Quitmann O’Neill Packaging LtdWrenTech Ltd

eConomIC develoPment

agenCy

Invest Northern Ireland

eduCatIon & traInIng

Ann McGeeCPI Technology Ltd Festo LtdGS1 Ireland Hazchem Training LtdHenley Forklift Group LtdPilz IrelandWaters Chromatography Ireland

eFFluent monItorIng/treatment

Axium ProcessP.J. Boner & Co. LtdCarbon GoupLancaster LaboratoriesNorgren Ireland LtdOcon Chemicals Ltd

eleCtrICal

Airpower DalkiaP.J. Boner & Co. Ltd

eleCtronIC ComPonents

Airpower Pilz Ireland

energy eFFICIenCy /management

Berkley Group Callaghan Engineering Cross Technical SolutionsDalkia Flexachem Manufacturing LtdIrish National Accreditation BoardSustainable Energy Authority of Ireland

engIneerIng servICes

Berkley GroupP.J. Boner & Co. LtdCallaghan Engineering Croom Precision MedicalDalkia Flexachem Manufacturing LtdHenley Forklift Group LtdPilz Ireland

envIronmental ConsultIng Callaghan Engineering Dawsonrentals Irl LtdEnva Ireland Ltd Pilz Ireland

envIronmental servICes/equIPment

P.J. Boner & Co. LtdEnva Ireland LtdH.R. Holfeld (Engineering) LtdOcon Chemicals LtdPilz IrelandQuitmann O’Neill Packaging Ltd

evaPorators

Cross Technical SolutionsFisher ScientificFlexachem Manufacturing LtdGraham Hart (Process Technology) Ltd

exhIBItIon desIgn & dIsPlay

Clip Ltd Ireland

exPlosIon ProoFIng

BS&B Safety Systems LtdHenley Forklift Group LtdNorgren Ireland LtdPilz IrelandSartorius Mechatronics Ltd

exPlosIon ProteCtIon /Panels

BS&B Safety Systems LtdCPI Technology Ltd Flexachem Manufacturing Ltd Henley Forklift Group LtdPilz Ireland

extruders

Flexachem Manufacturing Ltd WrenTech Ltd

FaCIlIty desIgn

Callaghan Engineering

FaCIlItIes management

Goliath Packaging Systems LtdHochtief Facility Management

FIllIng equIPment

Quitmann O’Neill Packaging LtdWeber Labelling & CodingWrenTech Ltd

FIlters

Airpower Axium ProcessCarbon GoupCPI Technology Ltd Fisher ScientificFlexachem Manufacturing LtdNorgren Ireland LtdOcon Chemicals LtdWrenTech Ltd

ge

ne

ra

l su

PP

lIe

rs


47

FIltratIon

Airpower Axium ProcessCPI Technology Ltd Enva Ireland LtdFlexachem Manufacturing LtdNorgren Ireland LtdOcon Chemicals LtdSciChem - CorkSciChem - Dublin

FIre deteCtIon/PreventIon/ ProteCtIon

Flexachem Manufacturing Ltd

Flow Control

Airpower P.J. Boner & Co. LtdCPI Technology Ltd Enva Ireland Ltd Fisher ScientificFlexachem Manufacturing LtdManotherm LtdNorgren Ireland LtdPetrochem Pipeline Supply LtdTyco Valves & Controls Ireland Ltd

FluId handlIng

Callaghan Engineering CPI Technology Ltd Fisher ScientificFlexachem Manufacturing LtdH.R. Holfeld (Engineering) LtdNorgren Ireland LtdPetrochem Pipeline Supply LtdSciChem - CorkSciChem - DublinWrenTech Ltd

Fume CuPBoards

Fisher ScientificSciChem - CorkSciChem - Dublin ProSys Containment and Sampling TechnologyWrenTech Ltd

FurnaCes

Fisher Scientific

SciChem - CorkSciChem - Dublin.

gas deteCtIon

Fisher ScientificH.R. Holfeld (Engineering) LtdSciChem - CorkSciChem - Dublin

gauges

P.J. Boner & Co. LtdFisher ScientificFlexachem Manufacturing LtdManotherm LtdNorgren Ireland LtdPetrochem Pipeline Supply Ltd

glassware

CPI Technology Ltd Fisher ScientificOcon Chemicals LtdSciChem - CorkSciChem - Dublin

grIndIng

CPI Technology Ltd

hazardous waste dIsPosal/treatment

Enva Ireland LtdHazchem Training LtdIndaver IrelandInterpacOcon Chemicals Ltd Quitmann O’Neill Packaging LtdSoltec (Ireland) Ltd

health & saFety/FIrst aId

Fisher ScientificHazchem Training LtdPilz Ireland

heat exChangers

Axium ProcessCPI Technology Ltd Cross Technical Solutions

Flexachem Manufacturing LtdGraham Hart (Process Technology) LtdPetrochem Pipeline Supply LtdWrenTech Ltd

heaters

Cross Technical Solutions

homogenIsers

CPI Technology Ltd Fisher ScientificFlexachem Manufacturing LtdSciChem - CorkSciChem - DublinWrenTech Ltd

hoses

CPI Technology Ltd Flexachem Manufacturing LtdHenley Forklift Group LtdMicro Hydraulics Ltd/Micro Industries IrelandNorgren Ireland Ltd

humIdIty/humIdIFIers

Dawsonrentals Irl LtdFisher ScientificInterpacManotherm Ltd

hydraulICs

Bosch Rexroth LtdCallaghan Engineering Henley Forklift Group LtdMicro Hydraulics Ltd/Micro Industries IrelandWrenTech Ltd

InCIneratIon

Enva Ireland Ltd Indaver IrelandSoltec (Ireland) LtdTyco Valves & Controls Ireland Ltd

ge

ne

ra

l s

uP

Pl

Ier

s


48

InCuBators

Fisher ScientificSciChem - CorkSciChem - DublinOcon Chemicals Ltd

InsPeCtIon equIPment

P.J. Boner & Co. LtdFlexachem Manufacturing LtdH.R. Holfeld (Engineering) LtdSartorius Mechatronics Ltd

InstrumentatIon

P.J. Boner & Co. LtdCallaghan Engineering Fisher ScientificFlexachem Manufacturing LtdManotherm LtdPetrochem Pipeline Supply LtdOcon Chemicals Ltd SciChem - CorkSciChem - DublinTyco Valves & Controls Ireland Ltd Weber Labelling & Coding

ItBerkley Group Callaghan Engineering Ocon Chemicals Ltd

Investment

Glanbia EstatesScience Foundation Ireland (SFI)

Investment

PromotIon agenCy IDA Ireland

laB equIPment/suPPlIes

P.J. Boner & Co. LtdCarbon GoupFisher ScientificOcon Chemicals LtdO’Flynn Medical Ltd ProSys Containment and Sampling

TechnologyQuitmann O’Neill Packaging LtdSartorius Mechatronics LtdSciChem - CorkSciChem - DublinWeber Labelling & CodingWrenTech Ltd

legal/FInanCIal/InsuranCe

MacLachlan & DonaldsonMatheson Ormsby Prentice

logIstICs

C+G Logistics GroupChemsource LogisticsKWE (Ireland) LtdMovianto IrelandWeber Labelling & Coding

lIFts & hoIsts

Airpower Goliath Packaging Systems LtdHenley Forklift Group LtdWrenTech Ltd

maChIne tools

Lister Machine Tools LtdSoltec (Ireland) Ltd

maIntenanCe

Carbon GoupCPI Technology Ltd Cross Technical SolutionsDalkia Festo LtdFlexachem Manufacturing LtdH.R. Holfeld (Engineering) LtdGoliath Packaging Systems LtdLister Machine Tools LtdSartorius Mechatronics LtdWaters Chromatography Ireland

materIals handlIng/ForklIFts/Pallet truCks

Dawsonrentals Irl LtdGoliath Packaging Systems LtdHenley Forklift Group LtdInterpacIrish Lift TrucksWrenTech LtdToyota Material Handling Ireland Ltd

meChanICal engIneerIng servICes

Axium ProcessBerkley Group Callaghan Engineering CPI Technology Ltd Croom Precision MedicalDalkia Henley Forklift Group LtdGoliath Packaging Systems LtdPilz IrelandTyco Valves & Controls Ireland Ltd

meChanICal & ProCess engIneerIng

Axium ProcessCallaghan Engineering CPI Technology Ltd Norgren Ireland LtdPilz IrelandWrenTech LtdTyco Valves & Controls Ireland Ltd

medICal devICe manuFaCture

B.Braun MedicalCroom Precision Medical

memBrane FIltratIon systems

microfiltrationAxium ProcessFisher ScientificnanofiltrationAxium ProcessFisher ScientificultrafiltrationAxium ProcessFisher Scientific

ge

ne

ra

l su

PP

lIe

rs


49

meters

CPI Technology Ltd Fisher ScientificManotherm LtdPetrochem Pipeline Supply Ltd

mICrosCoPes

Fisher ScientificOcon Chemicals LtdSciChem - CorkSciChem - Dublin

mIllIng

CPI Technology Ltd Flexachem Manufacturing LtdSciChem - CorkSciChem - DublinWrenTech Ltd

mIxers

CPI Technology Ltd Fisher ScientificFlexachem Manufacturing LtdSciChem - CorkSciChem - DublinTyco Valves & Controls Ireland Ltd WrenTech Ltd

noIse/odour Control

Enva Ireland Ltd

oem manuFaCturIng

B.Braun MedicalFlexachem Manufacturing LtdMedisize Ireland LtdTyco Valves & Controls Ireland Ltd

PaCkagIng/desIgn

AnectoCatalent Pharma SolutionsChesapeakeComplas Packaging LtdIndustrial Packaging LtdInterpacMeasom Freer

Millmount HealthcareNPP Group LtdPrimePac LtdQuitmann O’Neill Packaging LtdSmurfit Kappa IrelandWeber Labelling & Coding

PaCkagIng/maChInery

ChesapeakeGoliath Packaging Systems LtdInterpacMillmount HealthcareNPP Group LtdQuitmann O’Neill Packaging LtdWeber Labelling & CodingWrenTech Ltd

Pallets

Complas Packaging LtdGoliath Packaging Systems LtdHenley Forklift Group LtdInterpacQuitmann O’Neill Packaging LtdSmurfit Kappa IrelandWrenTech Ltd

PharmaCeutICal FaBrICatIon

Axium ProcessCatalent Pharma SolutionsCross Technical SolutionsProSys Containment and Sampling TechnologyTyco Valves & Controls Ireland Ltd

PIPes/Cores

CPI Technology LtdPetrochem Pipeline Supply LtdSmurfit Kappa Ireland

PlastIC ContaIners

ChesapeakeCPI Technology Ltd Fisher ScientificIndustrial Packaging LtdMeasom FreerMedisize Ireland LtdOcon Chemicals LtdPrimePac LtdSciChem - CorkSciChem - Dublin

WrenTech Ltd

PlastIC Cores / tuBes

Fisher ScientificFlexachem Manufacturing LtdSmurfit Kappa Ireland

PneumatICs

Airpower Bosch Rexroth LtdP.J. Boner & Co. LtdFisher ScientificFlexachem Manufacturing LtdNorgren Ireland Ltd

PollutIon Control

Callaghan Engineering Enva Ireland Ltd

Powder handlIng

Carbon GoupCPI Technology Ltd Flexachem Manufacturing LtdGoliath Packaging Systems LtdProSys Containment and Sampling TechnologyQuitmann O’Neill Packaging LtdTyco Valves & Controls Ireland Ltd WrenTech Ltd

Pressure measurements/swItChes/vessels

Airpower Axium ProcessP.J. Boner & Co. LtdBS&B Safety Systems LtdFlexachem Manufacturing LtdManotherm LtdNorgren Ireland LtdPetrochem Pipeline Supply Ltd

Pressure vessels

Airpower CPI Technology Ltd Flexachem Manufacturing LtdGraham Hart (Process Technology) Ltd H.R. Holfeld (Engineering) Ltd

ge

ne

ra

l s

uP

Pl

Ier

s


50

Petrochem Pipeline Supply LtdProSys Containment and Sampling TechnologyTyco Valves & Controls Ireland Ltd WrenTech Ltd

Pressure relIeF

AirpowerCPI Technology LtdFlexachem Manufacturing LtdManotherm LtdNorgren Ireland LtdPetrochem Pipeline Supply LtdPilz IrelandTyco Valves & Controls Ireland Ltd

PrInt PaCkagIng

Contego Packaging Group Healthcare (Formerly Nampak)

ProCess Control

Axium ProcessP.J. Boner & Co. LtdCallaghan Engineering H.R. Holfeld (Engineering) LtdManotherm LtdNorgren Ireland LtdPetrochem Pipeline Supply LtdPilz IrelandSartorius Mechatronics LtdTyco Valves & Controls Ireland Ltd Weber Labelling & Coding

ProCess desIgn

Callaghan Engineering Pilz IrelandWeber Labelling & CodingTyco Valves & Controls Ireland Ltd

ProCess & meChanICal

engIneerIng ContraCtors

Axium Process Pilz IrelandTyco Valves & Controls Ireland Ltd

ProjeCt management

Axium ProcessCallaghan Engineering Glanbia EstatesGoliath Packaging Systems LtdPilz Ireland

ProteCtIve ClothIng/aPParatus

Fisher Scientific

PumPs

CPI Technology Ltd Fisher ScientificFlexachem Manufacturing LtdH.R. Holfeld (Engineering) LtdProSys Containment and Sampling TechnologyWaters Chromatography Ireland

qualIty & ComPlIanCe

Ann McGee Consulting Ltd

r&dAxium ProcessLancaster LaboratoriesMedisize Ireland Ltd PPD Inc.Quintiles Ireland LtdSciChem - CorkSciChem - DublinTopchem Pharmaceuticals LtdTyco Valves & Controls Ireland Ltd WrenTech Ltd

reaCtors

CPI Technology Ltd Flexachem Manufacturing LtdTyco Valves & Controls Ireland Ltd

reCruItment

Berkley GroupBrightwaterCPL Science & EngineeringICDS Recruitment Consultants

Lancaster LaboratoriesMatheson Ormsby Prentice

reFrIgeratIon/FreezIng

Cross Technical SolutionsCRS Mobile Cold StorageDalkiaDawsonrentals Irl LtdOcon Chemicals Ltd SciChem - CorkSciChem - Dublin

renewaBle energy

Dalkia Sustainable Energy Authority of Ireland

roBotICs

ABB Ltd

sanItary tuBIng

CPI Technology Ltd Flexachem Manufacturing LtdPetrochem Pipeline Supply Ltd

sCada/dCs/mIsP.J. Boner & Co. Ltd

sCruBBers

Graham Hart (Process Technology) Ltd

sCreens

Flexachem Manufacturing Ltd

seals & gaskets

Flexachem Manufacturing LtdQuitmann O’Neill Packaging LtdTyco Valves & Controls Ireland Ltd

ge

ne

ra

l su

PP

lIe

rs


sIevIng

Fisher ScientificOcon Chemicals LtdWrenTech Ltd

soFtware

Sartorius Mechatronics LtdWeber Labelling & Coding

solvent reCovery/servICes

Associated Chemicals LtdCPI Technology Ltd Enva Ireland Ltd Indaver IrelandSoltec (Ireland) Ltd

staInless steel/FIttIngs/ProduCts

CPI Technology Ltd Festo Ltd Fisher ScientificInterpacPetrochem Pipeline Supply LtdQuitmann O’Neill Packaging LtdTyco Valves & Controls Ireland Ltd

steam equIPment

CPI Technology Ltd Flexachem Manufacturing LtdManotherm LtdPetrochem Pipeline Supply LtdTyco Valves & Controls Ireland Ltd

storage/BundIng

Carbon GoupCRS Mobile Cold StorageDawsonrentals Irl LtdEnva Ireland Ltd InterpacSciChem - CorkSciChem - DublinWrenTech Ltd

suPPly ChaIn management

Catalent Pharma SolutionsC+G Logistics GroupChesapeakeGS1 Ireland KWE (Ireland) LtdMovianto Ireland

taBletIng equIPment

Flexachem Manufacturing LtdGoliath Packaging Systems LtdProSys Containment and Sampling TechnologyWrenTech Ltd

tanks

Axium ProcessCeltic Forwarding LtdComplas Packaging LtdCPI Technology Ltd Quitmann O’Neill Packaging LtdWrenTech Ltd

temPerature Control

P.J. Boner & Co. LtdCross Technical SolutionsDawsonrentals Irl LtdFlexachem Manufacturing LtdManotherm LtdMovianto IrelandPetrochem Pipeline Supply LtdTyco Valves & Controls Ireland Ltd

testIng servICes

AnectoP.J. Boner & Co. LtdCPI Technology Ltd Cross Technical SolutionsIrish National Accreditation BoardLancaster LaboratoriesPPD Inc.Waters Chromatography Ireland

thermal ImagIng/thermograPhy

Dalkia Manotherm Ltd

tools

Airpower

transPort & logIstICs

C+G Logistics GroupCeltic Forwarding LtdChemsource LogisticsHazchem Training LtdIrish Lift TrucksKWE (Ireland) LtdMovianto IrelandQuitmann O’Neill Packaging Ltd

tuBe sets/dIsPosaBles

Fisher ScientificMicro Hydraulics Ltd/Micro Industries Ireland

vaCuum systems

AirpowerCPI Technology Ltd Fisher ScientificEnva Ireland Ltd Flexachem Manufacturing LtdNorgren Ireland LtdWrenTech Ltd

valves

AirpowerAxium ProcessBS&B Safety Systems LtdCPI Technology LtdFlexachem Manufacturing LtdManotherm LtdNorgren Ireland LtdPetrochem Pipeline Supply LtdProSys Containment and Sampling TechnologyTyco Valves & Controls Ireland Ltd

valIdatIon

Ann McGee Consulting LtdCallaghan Engineering Lancaster Laboratories Pilz IrelandPPD Inc.

51

ge

ne

ra

l s

uP

Pl

Ier

s

ge

ne

ra

l su

PP

lIe

rs


ventIlatIon

Callaghan Engineering Cross Technical Solutions

vIsIon systems

AirpowerWeber Labelling & Coding

warehouse management

Celtic Forwarding LtdChemsource LogisticsComplas Packaging LtdC+G Logistics Group Goliath Packaging Systems LtdMovianto Ireland

washIng equIPment

Goliath Packaging Systems LtdSciChem - CorkSciChem - DublinWrenTech Ltd

waste management/Balers/reCyClIng

Axium ProcessEnva Ireland Ltd Goliath Packaging Systems LtdInterpacOcon Chemicals LtdQuitmann O’Neill Packaging Ltd

water treatment

ABB LtdAssociated Chemicals LtdAxium Process

Carbon GoupEnva Ireland Ltd Flexachem Manufacturing LtdGoulding Chemicals LtdNorgren Ireland LtdTyco Valves & Controls Ireland Ltd

weIghIng

P.J. Boner & Co. LtdFisher ScientificGoliath Packaging Systems LtdSartorius Mechatronics LtdSciChem - CorkSciChem - DublinWeber Labelling & CodingWrenTech Ltd

52

Notes


Co

mP

an

y L

Ist

Ing

s

53

Company Listings

a

Abb LtdAddress: BelgardRoad, Tallaght,Dublin24.Tel: (01)4057300Fax: (01)4057327Email:[email protected]: www.abb.comBusiness: Lifesciencesolutions.

AirpowerAddress: Unit12F,SixCross Roads,BusinessPark, Waterford.Tel: (051)373937Fax: (051)820903Email: [email protected]: www.airpower.ieBusiness: Pneumatic Components.Contact: MarketingManager:StephenMurphy.

AnectoAddress: MervueBusiness Park,Co.Galway.Tel: (091)757404Fax: (091)757387Email: [email protected]: www.anecto.comBusiness: Dangerousgoods packagingtesting laboratory.

Ann McGee consuLtinG LtdAddress: Unit63,Grange Close,Baldoyle IndustrialEstate, Baldoyle,Dublin13.Tel: (01)8325948Fax: (01)8325949Email: [email protected]: www.annmcgee.comBusiness: Pharmaceutical Quality,Compliance andTraining Specialists.

AssociAted cheMicALs LtdAddress: 16DEuroBusiness Park,LittleIsland, Co.CorkTel: (021)4351014Fax: (021)4351015Email: [email protected]: ChemicalSuppliesContact: ManagingDirector: SylvesterCotter.

Atc AutoMAtion LtdAddress: UnitB7,CentrePoint BusinessPark, OakRoad, Dublin12.Tel: (01)4607070Fax: (01)4610771Email:[email protected]: www.atc.ie

AxiuM process Address: HendyIndustrial Estate,Hendy, Swansea, SA40XP.Tel: (0044)1792883882Fax: (0044)1792886049Email:[email protected]: www.axiumprocess.com

B

b. brAun MedicALAddress: 3NaasRoad IndustrialPark, Dublin12.Tel: (01)7091801Fax: (01)7091889Email: [email protected]: www.bbraun.comBusiness: OEMmanufacturing.Contact: BusinessUnit Manager:BillProctor

berkLey GroupAddress: Dublin: 509TheCapel Building, Mary’sAbbey, Dublin7. Cork: MillHouse, Carrigrohane, Co.Cork.Tel: (01)8724666 (021)4289600Email: [email protected]: www.berkley.ieContact: JoannaHouston

betco MArketinG LtdAddress: ExhamHouse, TheFingerpost, Douglas,Co.Cork.Tel: (021)4364999Fax: (021)4365739Email: [email protected]: www.betco.ieContact: ManagingDirector: DiarmuidHalpin

p.J. boner & co. LtdinstruMent & weiGhinG speciAListsAddress: 35WesternParkway BusinessCentre, BallymountDrive, Ballymount,Dublin12.Tel: (01)4505050Fax: (01)4505183Email: [email protected]: www.pjboner.comBusiness: Instrument& weighingspecialists. Calibrations.Contact: ManagingDirector: PatrickMichael Boner


Co

mP

an

y LIs

tIn

gs

54

bosch rexroth LtdAddress: Unit6,Lismard BusinessPark, TimahoeRoad, Portlaoise,CoLaois.Tel: (057)8678200Fax: (057)8678201Email: [email protected]: www.boschrexroth.ieBusiness: EngineeringContact: RegionalSales Manager: JohnDoran

brenntAG ireLAndAddress: Unit405, GreenogueBusiness Park,Rathcoole, Dublin24.Tel: (01)4013500Fax: (01)4053501Email: [email protected]: www.brenntag.ieContact: GeneralManager: BillMaher

briGhtwAterAddress: 36MerrionSquare, Dublin2.Tel: (01)6621000Fax: (01)6623900Email:[email protected]: www.brightwater.ieContact: EileenMoloney

bs&b sAfety systeMs LtdAddress: RaheenBusinessPark, Raheen,Co.Limerick.Tel: (061)484700 EmergencyDelivery: 0862410615 DirectLine: 0868385556Fax: (061)352240Email: [email protected]: www.bsb.ieBusiness: Pressurerelief devices.Contact: SalesManager: PatrickMurphy

C

cALLAGhAn enGineerinGAddress: Dublin: WentworthHouse, 19/20HoganPlace, LowerGrand CanalSt,Dublin2.Tel: (01)6614420Fax: (01)6614424 Cork: Suite257, Building1000, Units1201&1202, CityGate,Mahon, Cork.Tel: (021)2409099Fax: (021)2409009Email: [email protected]: www.calleng.ieBusiness: Multi-discipline consultingengineering andprojectmanage- mentcompany.

cAMidA LtdAddress: TowerHouse, NewQuay, Clonmel, Co.Tipperary.Tel: (052)6125455Fax: (052)6125466Email: [email protected]: www.camida.comContact: CompanySecretary: DeirdreMcGrath

cArbon GroupAddress: FactoryCross, Ringaskiddy, Co.Cork.Tel: +353(0)214378988 UKLocalLo-Call: (0044)8708504831Fax: +353(0)214378950Email:[email protected] [email protected]: www.carbon.ieBusiness: Pharmachemicals.Contact: AreaSalesManager: CarolDeegan

cAtALent phArMA soLutions Address: Unit26, CherryOrchard IndustrialEstate, Dublin10.Tel: (01)6200600Fax: (01)6262815Email:[email protected]: www.catalent.comBusiness: Contractmanufacturing capabilitiesaswellas packagingandprinted componentstothe pharmaceutical industry.Contact: DirectorofBusiness Development: DiarmuidWilson

ceLtic forwArdinG LtdAddress: Dublin: CelticHouse, 30Marlborough Street,Dublin1. Waterford: BelviewPort, Slieverue, Co.Waterford.Tel: (01)8656000 (051)851821Fax: (01)8746745 (051)851823Email: [email protected]: www.celticfwd.ieBusiness: Shipping.Contact: Director: FinbarrCleary SalesManager: GeraldKiernanDGSA TankDivision Manager: PattydeCourcey

c + G LoGistics GroupAddress: WestpointBusiness Park,NavanRoad, Mulhuddart,Dublin15.Tel: (01)8208455Fax: (01)8208457Email: [email protected]: www.cglogistics.ieContact: GeneralManager/ Director: PatrickWoganBusinessDevelopment Manager: CormacSarsfield


Co

mP

an

y L

Ist

Ing

s

cheMco ireLAnd Ltd.Address: Unit2, Stadium BusinessPark, BallycoolinRoad, Cappagh, Dublin11.Tel: (01)8293600Fax: (01)8855029Email: [email protected]: www.chemco.ieBusiness: Chemical Distribution.Contact: SalesDirector: PeterFitzgerald

cheMtek sALes LtdAddress: EstuaryHouse, NewStreet, Malahide, Co.Dublin.Tel: (01)8453766/63Fax: (01)8453172Email: [email protected]: www.chemtek.ie

cheMsource industriAL divisionAddress: Unit2,Stadium BusinessPark, BallycoolinRoad, Cappagh,Dublin11.Tel: (01)8829117Fax: (01)8855029Email: [email protected]: www.chemsource.ieBusiness: Chemical Distributors.Contact: Director: JohnFarrell

cheMsource LoGisticsAddress: Unit2,Stadium BusinessPark, BallycoolinRoad, Cappagh,Dublin11.Tel: (01)8853977Fax: (01)8853978Email: [email protected]: www.chemsource.ieBusiness: Warehousing, transport&logisticsContact: Director: SandyMcConnachie

chesApeAkeAddress: EnterpriseWay, HightownIndustrial Estate,Newtownabbey, Belfast,BT364EW.Tel: (0044)2890804000Fax: (0044)2890804301Email: [email protected]:www.chesapeake.com/pharmaBusiness: Pharmaceuticaland healthcarepackaging (cartons,labels, leafletsandmore).

coMpLAs pAckAGinG LtdAddress: NaasIndustrial Estate,DublinRoad, Naas,Co.Kildare.Tel: (045)874088/9Fax: (045)874090Email: [email protected]: www.complas.ie

cLip Ltd ireLAndAddress: FirstFloor, CillinHill, DublinRoad, Kilkenny.Tel: (086)8283620Email: [email protected]: www.clipdisplay.ieBusiness: Exhibitionand displayequipment manufactureand service.Contact: IrishSalesManager: PaulSmith

conteGo pAckAGinG Group heALthcAre (forMerLy nAMpAk heALthcAre)Address: Unit629 IDAIndustrialPark, NorthernExtension, OldKilmeadenRoad, Waterford.Tel: (051)595300Fax: (051)595309Email: [email protected]: www.contegopackaging.comBusiness: Carton&leaflet supplierstothe pharmaceutical industry.Contact: BusinessDevelopment Manager: MariaMoran

corcorAn cheMicALs LtdAddress: KingsbridgeHouse, 17-22Parkgate Street,Dublin8.Tel: (01)6330400Fax: (01)6793521Email: [email protected]:www.corcoranchemicals.comBusiness: Distribution.Contact: SalesDepartment

cpi technoLoGy LtdAddress: Unit5LinkRoad BusinessPark, Ballincollig,Co.Cork.Tel: (021)4874142Fax: (021)4878764Email: [email protected]:www.cpitechnology.comBusiness: Providersof ProcessEquipment.Contact: ManagingDirector: AdrianGiltinan

55


Co

mP

an

y LIs

tIn

gs

56

cpL science & enGineerinGAddress: 83MerrionSquare South,Dublin2.Tel: (01)6146000/ (01)6146132Fax: (01)6147274Email: [email protected]: www.cpl.ieBusiness: Recruitment.Contact:Science&Engineering Manager: JudithMoffett

crooM precision MedicAL Address: EnterpriseCentre, Croom, Co.Limerick.Tel: (061)397744Fax: (061)397639Email:[email protected]: www.croomprecision.comBusiness: Medicaldevice manufacture.Contact: ManagingDirector: PatrickByrnes

cross technicAL soLutionsAddress: Unit26,Second Avenue,Cookstown IndustrialEstate, Cookstown,Tallaght, Dublin24.Tel: (01)4056777Fax: (01)4136932Email: jmcgrath@cross technicalsolutions.ieWeb: www.crosstechnical solutions.ieBusiness: Refrigeration.Contact: TechnicalDirector: JonathanMcGrath GeneralManager: JasonKeating

crs MobiLe coLd storAGeAddress: ArcticHouse, Carnisle, Kildalkey, Co.MeathTel: (046)9435000Fax: (046)9435068Email: [email protected]: www.crs.ie

Business: Coldstorage, pharmaceutical storage,bespoke refrigerationContact: JohnTyrell

D

dALkiA

Address: 145LakeviewDrive, AirsideBusinessPark, Swords,Co.Dublin.Tel: (01)8701200Fax: (01)8701201Email: [email protected]: www.dalkia.ieContact: ManagingDirector: PatGilroy IndustrialDirector Pharmaceutical& Health: FergusElebert

dAwsonrentALs irL. LtdAddress: Unit20Tougher BusinessPark, Newhall,Naas, Co.Kildare.Tel: (045)448810Fax: (045)448811Email: [email protected]:www.dawsonrentalsireland.comBusiness: Temperature ControlSolutions.Contact: Director: AidanMcCauley

EenvA ireLAnd LtdAddress: RaffeenIndustrial Estate,Ringaskiddy, Co.Cork.Tel: (021)4387200Fax: (021)4387299Email: [email protected]: www.enva.ie

environMentAL protection AGencyAddress: POBox3000, JohnstownCastle Estate, Co.Wexford.Tel: (053)9160600Fax: (053)9160699Email: [email protected]: www.epa.ie

euroLec instruMentAtion LtdAddress: TechnologyHouse, CluanEnda, Dundalk, Co.Louth.Tel: (042)9333423Fax: (042)9331758Email: [email protected]:www.eurolec-instruments.comBusiness: Electronic instrumentation.Contact: Sales/Marketing Executive: ChrisMears

F

festo LtdAddress: Unit5, SandyfordPark, SandyfordIndustrial Estate, Dublin18.Tel: (01)2954955Fax: (01)2955680Email:[email protected]: www.festo.com/ieBusiness: Automation companyspecialising infactoryand processautomation.Contact: SalesManager: DiarmaidCowhie


Co

mP

an

y L

Ist

Ing

s

57

fisher scientificAddress: Suite4,Plaza212, Blanchardstown CorporatePark2, Ballycoolin, Dublin15.Tel: (01)8855854Fax: (01)8991855Email: [email protected]: www.ie.fishersci.comBusiness: Laboratory supplies.Contact: Marketing Manager: GerryFitzmaurice

fLexAcheM MAnufActurinG LtdAddress: Donnybrook CommercialCentre, Douglas,Co.Cork.Tel: (021)4617200Fax: (021)4891297Email: [email protected]: www.flexachem.comBusiness: Manufacturer/ Distributor.Contact: CommercialDirector: AgnesMullins

g

GLAnbiA estAtesAddress: GlanbiaHouse, RingRoad, Co.Kilkenny.Tel: +353(0)872564339Email:[email protected]:www.kilmeadenfields.comBusiness: PropertyBusiness UnitofGlanbiaPLC.Contact: CEO:GerMullally

GoLiAth pAckAGinG systeMs LtdAddress: Beechwood,Nenagh, Co.Tipperary.Tel: (067)37893Fax: (067)34794Email: [email protected]: www.goliath.ieBusiness: Supply& installationof packagingequipment andmaterials handlingsystems.Contact: Director: GeorgeO’Leary

GouLdinG cheMicALs LtdAddress: CentreParkRoad, Marina,CorkCity.Tel: (021)4911611Fax: (021)4911660Email:[email protected]: www.gouldings.ieBusiness: Chemical distributor.

GrAhAM hArt (process technoLoGy) LtdAddress: FriarsInd.Estate, BradfordRoad, Idle,Bradford, BD108SW,UK.Tel: (0044)1274617021Fax: (0044)1274618614Email: [email protected]:www.graham-hart.comContact: SalesDirector: StephenHart

Gs1 ireLAndAddress: TheNutleyBuilding, MerrionRoad, Dublin4.Tel: (01)2080660Fax: (01)2080670Email:[email protected]: www.gs1ie.orgContact:MemberSupportServices:KarenMurphy

H

hAzcheM trAininG LtdAddress: G10,Maynooth BusinessCampus, Maynooth, Co.Kildare.Tel: (01)6291800Fax: (01)6291822Email:[email protected]: www.hazchem.ieContact: Director: MichelleCleere

henLey forkLift Group LtdAddress: HenleyIndustrial Park,KilleenRoad, Dublin10.Tel: (01)6209200Fax: (01)6265406Email: [email protected] [email protected]: www.henley.ieBusiness: Forklifts& Warehousing Equipment. Specialistsin flameproofforklift trucks.Contact: Director: MarkKenny Director: BrianO’Connell

hochtief fAciLity MAnAGeMentAddress: Ireland: HOCHTIEFFacility Management IrelandLtd., LandscapeHouse, LandscapeRoad, Churchtown, Dublin14. UK: HOCHTIEFFacility ManagementUKLtd, HOCHTIEFHouse, 2IbisCourt, CentrePark, WarringtonWA11RLTel: (01)2157000 +441925404500Fax: (01)2157070 +441925404598Email:Web: www.hochtief-fm.ie


Co

mP

an

y LIs

tIn

gs

58

Business: Facilities Management.Contact: RegionOperations Manager: RayCasey

h.r. hoLfeLd (enGineerinG) LtdAddress: 2-4MervilleRoad, Stillorgan, Co.Dublin.Tel: (01)2887361Fax: (01)2887380Email: [email protected]: www.holfeld.ieType of ProcessPump Business: Supplier.Contact: Business Development& KeyAccounts: EmmetConnelly

hrb cLinicAL reseArch fAciLity

Address: NUIGalway, GeataanEolais,

UniversityRoad, Galway.

Tel: (091)495892Fax: (091)526027Email: [email protected]: www.crfg.ieBusiness: ClinicalResearchContact: ProgrammeManager: LisaDaly

iicds recruitMent consuLtAntsAddress: 24UpperFitzwilliam Street,Dublin2.Tel: (01)6321200Fax: (01)6762079Email:[email protected]: www.icds.ieBusiness: Recruitment consultants.Contact: Recruitment Director: AnthonyMcLoughlin

idA ireLAnd Address: WiltonParkHouse, WiltonPlace, Dublin2.Tel: (01)6034000Email:[email protected]: www.idaireland.comBusiness: Investment promotionagency.Contact: GlobalHeadofLife Sciences: DavidShanahan

indAver ireLAndAddress: 4HaddingtonTerrace, DunLaoghaire, Co.Dublin.Tel: (01)2804534Fax: (01)2807865Email:[email protected]: www.indaver.ieBusiness: Hazardous&non- hazardouswaste disposalandrecovery ensuringfull compliance.

industriAL pAckAGinG LtdAddress: KillarneyRoad, Bray,Co. Wicklow.Tel: (01)2864010Email: [email protected]: www.industrialpackaging.ieBusiness: Manufacturerof fibredrums.Contact: ManagingDirector: NormanLee

interpAcAddress: 67EHeatherRoad, SandyfordIndustrial Estate,Dublin18.Tel: (01)2940600Email: [email protected]: www.interpac.ie

Business: Packaging.

Contact: ManagingDirector: IanSutton

invest northern ireLAndAddress: BedfordSquare, BedfordStreet, Belfast,BT27ES.Tel: (048)90698601Fax: (048)90436536Email: [email protected]: www.investni.comBusiness: Economic developmentagency.Contact: PatriciaO’Neill

irish exporters AssociAtion - Life sciences ireLAnd Address: 28MerrionSquare, Dublin2.Tel: (01)6612182Fax: (01)6612315Email: [email protected]: www.irishexporters.orgBusiness: LifeSciences IrelandisIndustry Groupingwithinthe IrishExporters Association.

irish Lift trucksAddress: ClonlaraAvenue, BaldonnellBusiness Park,Baldonnell, Dublin22.Tel: (01)4034100Fax: (01)4034183Email: [email protected]: www.irishlifttrucks.ieBusiness: MaterialsHandling Equipment/Hyster Forklifts/Lancer SideloadersContact: GeneralManager: ConalMcCourt

irish nAtionAL AccreditAtion boArd, the

Address: WiltonParkHouse, WiltonPlace, Dublin2.


Co

mP

an

y L

Ist

Ing

s

59

Tel: (01)6073003Fax: (01)6073109Email: [email protected]: www.inab.ieBusiness: Provides accreditation oflaboratories, certification& inspectionbodies. Contact: InformationOfficer: OrlaDoyle

J

JAvA cLinicAL reseArch LtdAddress: FitzwilliamBuiness Centre,26Upper PembrokeSt, Dublin2.Tel: 016373903Fax: 016373907Email: [email protected]: www.javacr.comBusiness: ClinicalResearchContact: ManagingDirector: RuthNallen

K

kwe (ireLAnd) LtdAddress: Dublin:Unit4 HorizonLogistics Park,NewNaulRd, Harristown, Swords,Co.Dublin. Cork: Unit4&5, SouthRing WestBusinessPk, TramoreRoad, Co.Cork.Tel: (01)8239600 (021)4975722Fax: (01)8361111 (021)4975727Email:[email protected]@ea.kwe.comWeb: www.kwe.comContact: SalesManager: KarlO’Reilly

L

LAncAster LAborAtoriesAddress: IDABusinessPark, Clogherane, Dungarvan, Co.WaterfordTel: (058)48300Fax: (058)42855Email:[email protected]: www.lancasterlabspharm.comBusiness: ContractAnalytical ServicesContact: BusinessDevelopment Director: MarkGlass

Lennox LAborAtory suppLies LtdAddress: JohnF.Kennedy Drive,NaasRoad, Dublin12.Tel: (01)4552201Fax: (01)4507906Email: [email protected] [email protected]: www.lennox.ieBusiness: Laboratorysuppliers.

Lister MAchine tooLs LtdAddress: POBox838, BluebellIndustrial Estate, Dublin12.Tel: (01)4508866Fax: (01)4509836Email:[email protected]:www.listermachinetools.comBusiness: Saleofmachine tools&associated equipment.

m

MAcLAchLAn & donALdsonAddress: 47MerrionSquare, Dublin2.Tel: (01)6763465Fax: (01)6612083Email: [email protected]:www.maclachlan.ieBusiness: IntellectualProperty AttorneysContact: Dr.YvonneMcKeown

MAnotherM LtdAddress: 4WalkinstownRoad, Dublin12.Tel: (01)4522355Fax: (01)4516919Email: [email protected]: www.manotherm.ie Business: Distributorsofcontrolsandinstrumentation.Contact: ManagingDirector: R.C.Gilbert

MAtheson orMsby prenticeAddress: 70SirJohn Rogerson’sQuay, Dublin2.Tel: (01)2322000Fax: (01)2323333Web:www.mop.ieBusiness: Lawfirm

MeAsoM freerAddress: 37-41Chartwell Drive,Wigston, Leicester,LE182FL, UK.Tel: (0044)1162881588Fax: (0044)1162813000Email: [email protected]: www.measomfreer.co.ukBusiness: Manufacturer.Contact: SalesDirector: MarkFreer

Medisize ireLAnd LtdAddress: HighRoad,Letterkenny, Co.Donegal.Tel: (074)9188549Email: [email protected]: www.medisize.comBusiness: Contractmanufacturerofprimarypharmaceuticalpackagingandmedicalanddiagnosticdevices.Contact: Business Development Manager:MarieNelis


Co

mP

an

y LIs

tIn

gs

60

Micro hydrAuLics Ltd/Micro industries ireLAndAddress: Dublin: 2003Orchard Avenue,Citywest BusinessCampus, Dublin24.Tel: (01)4639100Fax: (01)4105609 Cork: Unit6/7Cherrywood BusinessPark, LittleIsland, Co.Cork.Tel: (021)4510570Fax: (021)4510572Email:[email protected]: www.microhydraulics.ieBusiness: Sanitaryhose, tube,sets/disposable.Contact: SalesRepresentative: RalphFitzsimons SalesRepresentative: DaveO’Donavan

MiLLMount heALthcAre Address: Block7,CityNorth BusinessCampus, Stamullen, Co.Meath.Tel: (01)8418300Fax: (01)8418039Email: [email protected]:www.millmounthealthcare.ieBusiness: Full-service contractpackaging serviceproviderfor thepharmaceutical industry.Fully licensedforprimary/ secondarypackaging, warehousingandEU batchreleases.Contact: ManagingDirector: PascalKeogh

MoviAnto ireLAnd Address: Pharmapark, Chapelizod, Dublin20.Tel: (01)6305305Fax: (01)6305400Email: [email protected]: Moviantoisalogistics

anddistributionserviceprovider,specialising

inthepharmaceutical, biotechnologyand

healthcareindustries.Contact: CommerialDirector: JamesQuinn

nnAtionAL cheMicAL co. Ltd Address: NCCHouse, 42LowerLeesonSt., Dublin2.Tel: (01)6131400Fax: (01)6340132Email: [email protected]: www.ncc.ieBusiness: Distributor.Contact: SalesDirector: ChristySmith

norGren ireLAnd LtdAddress: 137SlaneyClose, DublinIndustrial Estate,Glasnevin, Dublin11.Tel: (01)8300288Fax: (01)8300082Email: [email protected]: www.norgren.comBusiness: Fluidandmotion control.‘Pneumatics’ automation components.

npp Group LtdAddress: Unit509, MitchelstownRoad, NorthwestBusiness Park,Ballycoolin, Blanchardstown, Dublin15.Tel: (01)8809299Email: [email protected] [email protected]: www.npp.ieBusiness: Flexiblepackaging suppliers& distributors.Contact: SalesDirector: EoinMcDonagh

oocon cheMicALs LtdAddress: Unit5,SouthCork IndustrialEstate, VicarsRoad, Pouladuff,Co.Cork.Tel: (021)4318555Fax: (021)4318560Email:[email protected]:www.oconchemicals.comContact: ManagingDirector: FrankMulcahy

o’fLynn MedicAL LtdAddress: Westend,Millstreet, Co.Cork.Tel: (029)21799Fax: (029)70191Email:[email protected]:www.oflynnmedical.comBusiness: Distributorof Scrubex“Automated ProtectiveClothing Distributor”Contact: ManagingDirector: TadhgO’Flynn


Co

mP

an

y L

Ist

Ing

s

61

p

petrocheM pipeLine suppLy LtdAddress: Cork: Unit14,Euro BusinessPark, LittleIsland, Co.Cork.Tel: (021)4351300Fax: (021)4351166Email: [email protected]: www.petrochem.ieContact: SalesManager: DaveAhernAddress: Dublin: EuropaHouse DunboyneBusiness Park,Dunboyne, Co.Meath.Tel: (01)8026020Fax: (01)8015860Email: [email protected]: www.petrochem.ieContact: NoelDonnelly, DeclanMurphyBusiness: Supplierof StainlessSteelPipes, Fittings,Flanges, Fasteners, Valves,Steam Products, Instrumentationand ControlstotheIrish Pharmaceuticaland Biotechmarkets.

piLz ireLAndAddress: CorkBusiness& TechnologyPark, ModelFarmRoad, CoCork.Tel: (021)4346535Fax: (021)4804994Email: [email protected]: www.pilz.ieBusiness: Processand machinerysaftey engineeringservices andtraining.Contact: SalesManager: AndrewDonnelly MD:JohnMcAuliffe

p.k. cheMicALs LtdAddress: Unit23,Sandyford OfficePark, BlackthornAvenue, Foxrock,Dublin18.Tel: (01)2956977Fax: (01)2958338Email: [email protected]: Chemical Distributor.Contact: PurchasingandSales Manager: SarahMurphy

ppd, inc.Address: BuildingC, AthloneBusiness& TechnologyPark, Garrycastle,Athlone, Co.WestmeathTel: (0906)460300Fax: (0906)460301Email: [email protected]: www.ppdi.comBusiness: ContractResearch OrganisationContact: Director,GMPLabs, Europe: SusanNeenan

priMepAc LtdAddress: Unit2, CaulsideDrive, NewparkIndustrial Estate, Antrim, BT412DU.Tel: (0044)2894428188Fax: (0044)2894428177Email: [email protected]: www.primepacltd.comBusiness: Manufacturer& supplierofplastic containers.Contact: Director: JohnMcGahon

prosys contAinMent And sAMpLinG technoLoGyAddress: RosehillBusiness Centre,Ballinacurra, Midleton, Co.Cork.Tel: (021)4613890Fax: (021)4613891Email: [email protected]: www.prosys.ieBusiness: Designand maunfactureof samplingand isolatorsforthe pharmaceuticaland chemicalindustries.Contact: ManagingDirector: MichaelMcLoughlin

Q

QuintiLes ireLAnd LtdAddress: EastpointBusiness Park,Fairview, Dublin3.Tel: (01)8195100Fax: (01)8099500Web: www.quintiles.comBusiness: ClinicalResearch andDevelopmentContact: ManagingDirector: JohnKiernan

QuitMAnn o’neiLL pAckAGinG LtdAddress: St.Brendan’sRoad, Portumna, Co.Galway.Tel: (090)9741148/9Fax: (090)9741459Email:[email protected]: www.qonpack.comBusiness: Packagingstockist &distributors.Contact: GeneralManager: DavidO’Neill


Co

mP

an

y LIs

tIn

gs

62

s

sArtorius MechAtronics uk LtdAddress: Unit41,TheBusiness Centre,Stadium BusinessPark, BallycoolinRoad, Dublin11.Tel: (01)8089050Fax: (01)8089388Email: info.ireland@ sartorius.comWeb: www.sartorius.ieBusiness: Laboratory& processtechnology provider.Sales& serviceoflaboratory &processweighing equipment.Contact: NickParsons

scicheM - corkAddress: Unit14, BarryscourtBusiness Park,Carrigtwohill, Co.Cork.Tel: (021)4882388Fax: (021)4882389Email: [email protected]: www.scichem.comBusiness: Laboratory Suppliers.Contact: BranchManager: JohnMolloy

scicheM - dubLinAddress: GreenhillsIndustrial Estate,Walkinstown, Dublin12.Tel: (01)4504077Fax: (01)4504328Email: [email protected]: www.scichem.comBusiness: Laboratory Suppliers.Contact: BranchManager: SeamusAmond

science foundAtion ireLAnd (sfi)Address: WiltonParkHouse, WiltonPlace, Dublin2.Tel: (01)6073200Fax: (01)6073201Email: [email protected]: www.sfi.ie

Business: Government fundingagency forresearch.Contact: HeadofIndustry- ResearchDevelopment: Dr.PaulDodd

sMurfit kAppA ireLAndAddress: BallymountRoad, Walkinstown, Dublin12.Tel: (01)4090000Fax: (01)4564506Email: [email protected]: www.smurfitkappa.ie www.skpackaging.ieBusiness: Packaging.Contact: MarketingManager: MarkMunnelly

soLtec (ireLAnd) LtdAddress: ZoneA,Mullingar BusinessPark, Mullingar, Co.Westmeath.Tel: (044)9335133Email: [email protected]: www.soltec.ieBusiness: SoltecisIreland’s onlycommercially operatedsolvent recyclingplant.Solid hazardouswaste collectionsalso provided.Contact: BusinessDevelopment Manager: MichaelCorcoran

sustAinAbLe enerGy Authority of ireLAnd Address: Glasnevin,Dublin9.Tel: (01)8369080Fax: (01)8372848Email: [email protected]: www.sei.ieBusiness: Energyadvice& information.

t

topcheM phArMAceuticALs LtdAddress: BallymoteBusiness Park,Carrownanty, Ballymote, Co.Sligo.Tel: (071)9189685Fax: (071)9197864Email:[email protected]:www.topchempharma.comBusiness: Developmentand manufactureof pharmaceuticalactive ingredients.Contact: ManagingDirector: DonalCoveney

toyotA MAteriAL hAndLinG ireLAnd LtdAddress: KilleenRoad, Dublin12.Tel: (01)4190321Fax: (01)4190325Business: Forkliftand WarehouseSupplies.Contact: SalesManager: RobertO’Reilly

tyco vALves & controLs ireLAnd LiMitedAddress: VictoriaHouse, BeaumontAvenue, Churchtown, Dublin14.Tel: (01)2951101Email:[email protected]:www.tycoflowcontrol-eu.comBusiness: Industrialvalves& controls.Contact: GeneralManager: TonyKilbane


Co

mP

an

y L

Ist

Ing

s

63

U

univAr LtdAddress: 536GrantsCrescent, GreenogueBusiness Park,Rathcoole, Co.Dublin.Tel: (01)4019800Fax: (01)4019142Email: pharma.sales@ univareurope.comWeb:www.univareurope.comBusiness: Ingredients- pharmaindustry includingAPI’s, excipients,process chems,solvents& intermediates.Contact: AccountManager: JohnMcCluskey

W

wAters chroMAtoGrAphy ireLAndAddress: Unit3.1Woodford BusinessPark, Santry,Dublin9.Tel: (01)4481500Fax: (01)4481510Email: [email protected]: www.waters.comBusiness: Thecompany designs,manufactures, sellsandservices HPLC,UPLC, massspectrometry instrumentsystems andsupportproducts, includingchemistry consumablesand post-warranty serviceplans.Contact: NationalSales Manager: DavnetDonnelly

weber LAbeLLinG & codinGAddress: KilcannonInd.Est., OldDublinRoad, Enniscorthy, Co.Wexford.Tel: (053)9233778Fax: (053)9233284Email:[email protected]:www.weberireland.comContact: OperationsManager: PatrickHughes

wrentech LtdAddress: Eversley, ChurchBayRoad, Crosshaven, Co.Cork.Tel: (021)4832644Fax: (021)4831363Email: [email protected]: www.wrentech.ieContact: SalesAdministrator: SiobhanMurray

Notes

64

ACADEMY OF MEDICAL LABORATORY SCIENCE Tel: (01) 677 5602 E-mail: [email protected] Web: www.amls.ie

ADvISORY COuNCIL FOR SCIENCE, TEChNOLOgY & INNOvATIONTel: (01) 607 3162E-mail: [email protected]: www.sciencecouncil.ie

AN BORD PLEANALATel: (01) 858 8100LoCall: 1890 275 175E-mail: [email protected]: www.pleanala.ie

ChAMBERS IRELAND Tel: (01) 400 4300E-mail: [email protected]: www.chambers.ie

COMPANIES REgISTRATION OFFICETel: (01) 804 5200LoCall: 1890 220 226E-mail: [email protected]: www.cro.ie

uCD SChOOL OF ChEMICAL & BIOPROCESS ENgINEERINgTel: (01) 716 1825E-mail: [email protected]: www.ucd.ie/chembioeng

DEPT. OF JOBS, ENTERPRISE & INNOvATIONTel: (01) 631 2121LoCall: 1890 220 222E-mail: [email protected]: www.djei.ie

DEPT. OF ThE ENvIRONMENT, COMMuNITY & LOCAL gOvERNMENTTel: (01) 888 2000LoCall: 1890 20 20 21E-mail: [email protected]: www.environ.ie

ELECTRICITY SuPPLY BOARDTel: 1850 372 372E-mail: [email protected]: www.esb.ie

ENTERPRISE IRELANDTel: (01) 727 2000E-mail: [email protected]: www.enterprise-ireland.com

ENvIRONMENTAL hEALTh OFFICERS’ ASSOCIATIONTel: (01) 276 1211E-mail: [email protected]: www.ehoa.ie

ENvIRONMENTAL PROTECTION AgENCYTel: (053) 916 0600LoCall: 1890 335 599E-mail: [email protected]: www.epa.ie

BIOTEChNOLOgY IRELANDTel: (01) 727 2692E-mail: [email protected]

FAS - TRAININg & EMPLOYMENT AgENCYTel: (01) 607 0500E-mail: [email protected]: www.fas.ie

FORFASTel: (01) 607 3000E-mail: [email protected]: www.forfas.ie

hEALTh AND SAFETY AuThORITYTel: (01) 614 7020Lo Call: 1890 289 389E-mail: [email protected]: www.hsa.ie

hEALTh RESEARCh BOARDTel: (01) 234 5000E-mail: [email protected]: www.hrb.ie

hIghER EDuCATION AuThORITYTel: (01) 231 7100E-mail: [email protected]: www.hea.ie

IDA - INDuSTRIAL DEvELOPMENT AgENCY Tel: (01) 603 4000E-mail: [email protected]: www.idaireland.com

INSTITuTE OF ChEMISTRY OF IRELANDE-mail: [email protected] Web: www.instituteofchemistry.org

INTERNATIONAL SOCIETY FOR PhARMACEuTICAL ENgINERINg (ISPE)Tel: +32 2 743 4422E-mail: [email protected]: www. ispe.org

IRISh BIOINDuSTRY ASSOCIATIONTel: (01) 605 1584E-mail: [email protected]: www.ibec.ie/ibia

IRISh BuSINESS & EMPLOYERS CONFEDERATION (IBEC)Tel: (01) 605 1500 E-mail: [email protected] Web: www.ibec.ie

IRISh CLEANROOM SOCIETYTel: (091) 790693E-mail: [email protected]: www.cleanrooms-ireland.ie

IRISh COSMETICS, DETERgENT & ALLIED PRODuCTS ASSOCIATION Tel: (01) 605 1671E-mail: [email protected]: www.icda.ie

IRISh EXPORTERSASSOCIATIONTel: (01) 661 2182E-mail: [email protected] Web: www.irishexporters.ie

IRISh MEDICAL DEvICES ASSOCIATIONTel: (01) 605 1564E-mail: [email protected]: www.ibec.ie/imda

IRISh MEDICINES BOARDTel: (01) 676 4971E-mail: [email protected]: www.imb.ie

IRISh NATIONAL ACCREDITATION BOARDTel: (01) 607 3003E-mail: [email protected]: www.inab.ie

IRISh PATENTS OFFICE Tel: (056) 772 0111E-mail: [email protected] Web: www.patentsoffice.ie

IRISh PhARMACY uNIONTel: (01) 493 6401E-mail: [email protected] Web: www.ipu.ie

IRISh vENTuRE CAPITAL ASSOCIATION Tel: (01) 276 4647E-mail: [email protected] Web: www.ivca.ie

INvEST NORThERN IRELANDTel: (01) 234 2533E-mail: [email protected] Web: www.investni.com

MANDATE TRADE uNION Tel: (01) 874 6321E-mail: [email protected] Web: www.mandate.ie

NATIONAL INSTITuTE FOR TRANSPORT & LOgISTICS (NITL)Tel: (01) 402 3000E-mail: [email protected]: www.nitl.ie

PARENTERAL DRug ASSOCIATION (PDA)Tel: +1 (301) 656 5900E-mail: [email protected]: www.pda.org

PhARMAChEMICAL IRELANDTel: (01) 605 1584E-mail: [email protected] Web: www.pharmachemicalireland.com

PhARMACEuTICAL SOCIETY OF IRELAND Tel: (01) 218 4000E-mail: [email protected]: www.thepsi.ie

REPAKTel: (01) 467 0190E-mail: [email protected] Web: www.repak.ie

SCIENCE FOuNDATION IRELANDTel: (01) 607 3200E-mail: [email protected] Web: www.sfi.ie

Ir Ish PharmaChem 2011

UsefUl RefeRences

Securing the Supply chain

Cutting supply chain costs to improve profitability has never been more of a priority for Irish phar-

maceutical companies, competing with overseas plants for survival. Throughout the sector, companies are looking for ways to re-engineer their processes, to drive out inef-ficiencies and to create greater visibility and security across their supply chains.

Supply chain visibility is about knowing where objects (e.g. raw materials, their containers, as well as finished goods and assets) are and where they have been. When combined with easy access to production data, such as expiry dates or batch numbers, manufac-turers can transform into highly responsive, flexible and lean organisations.

Visibility means leveraging standards and business applications to see more “event-based” product informa-tion, which is critical for dynamic inventory manage-ment, tracking, tracing and product authentication, as well as meeting regulatory requirements.

SerialiSation regulationS

The pending serialisation regulations, which will require the serialisation of medicines and medical devices, will require significant investment, but the resulting visibility of product across the supply chain will more than compensate in terms of reduction of out-of-stocks and product wastage, improved expi-ration management, efficiency gains, and critically, patient safety.

Linking and validating the physical flow of raw materials and goods with production data about them can only be successfully achieved through the adoption of open, global standards. Manufacturers are looking to enabling technologies such as bar-coding, RFID and electronic messaging (EDI) to automate processes, enhance visibility and enable interoperability. Indeed the adoption, by upstream raw materials suppliers, of GS1 standards-based product and asset identification systems, coupled with EDI, greatly enhances the abil-ity of all parties to secure the chain of custody, of both raw ingredients and finished products throughout the healthcare supply chain.

CaSe StudieS

A number of Irish organisations are already to the fore in deploy-ing standards-based solutions for product identification, authentica-tion, traceability and supply chain visibility.

9

Supply Chain

Maria Svejdar, Marketing Manager, GS1, examines how the adoption of GS1 standards-based product and asset identification systems, coupled with EDI,

greatly enhances the ability of all parties to secure the chain of custody, of both raw ingredients and finished products throughout the healthcare supply chain.

CLASS Demonstrates Visibility and InteroperabilityLate last year, The Galway Clinic in conjunction with GS1 Ireland, Georgia Tech Research Ireland, the Western Vascular Institute and three of the top endovascular device manufacturers piloted a GS1 EPC standards-based RFID supply chain visibility solution. The aim of the project was to develop a model for endovascular-device tracking to include RFID technology and bar codes from the point of manufacture to the operating room, to improve supply chain effi-ciency and reduce the cost of missing or expired items.

“With 10 to 20 procedures performed each day, the last thing surgeons need to worry about is whether the right product is in stock or if it has passed its expiry date,” said Sherif Sultan, the clinic’s consultant vascular and endovascular surgeon. “The CLASS project demonstrated that UHF RFID tags could identify and track the movement of high-value endovascular devices to improve patient safety and lower costs by reducing the risk of errors, out-of-stocks and product expiration,” said Kevin McGuinness, Senior Project Manager at Georgia Tech Ireland.

For further information on GS1 Standards for unique product, asset and location identification within the Pharma-Chemical industry please call 01 2080660.

An Irish Product Authenticationand Traceability Best Practice SolutionThe National Centre for Hereditary Coagulation Disorders has implemented a world-class warehousing, distribution, stock manage-ment and traceability system based on GS1’s open, global standards. The solution, which tracks medication used for the treatment of haemophilia, is regarded internationally as best practice. The system has delivered a return on investment within a very short timeframe, reducing wastage and very significantly eliminating over €5m in surplus stock from the supply chain.

The system is also being further developed to extend the trace-ability capabilities right to the point of administration in the patient’s home. A new mobile phone app enables patients to check a product’s expiry and recall status and following treatment, the app updates both the electronic patient record and the warehouse management system, ensuring a constant cycle of real-time product and data visibility.

Documents

Irish PharmaChem 2011